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Abstract 
Virus attachment to the host cell surface and subsequent cell entry are key steps in viral 
infection. Neutralizing antibodies therefore often target virus proteins that mediate 
binding to cell receptors.  
Mammalian orthoreoviruses (reoviruses) are useful models for studies of viral 
pathogenesis and host immunity, and they are promising oncolytic agents and vectors for 
vaccines. The reovirus attachment protein σ1 engages junctional adhesion molecule-A 
(JAM-A) and sialylated carbohydrate receptors. During the acid-dependent proteolysis 
from virions to infectious subvirion particles (ISVPs), which accompanies cell entry, the 
σ1 protein is thought to undergo a structural rearrangement.  
In this thesis, the attachment protein σ1 of type 1 (T1) and type 3 (T3) reovirus were 
structurally analyzed in complex with antigen-binding fragments (Fabs) of the serotype-
specific neutralizing antibodies 5C6 and 9BG5, respectively. The crystal structures 
allowed us to determine the complete antibody epitopes and to explain how reovirus 
variants can escape neutralization. Surface-plasmon resonance was used to investigate 
the interplay between JAM-A and antibody binding and to determine affinities of JAM-A 
and the Fabs for σ1. Together with the analysis of hemagglutination inhibition and cell-
binding assays, we were able to propose a mechanism for how the antibodies neutralize 
reovirus infection. We observed strikingly different hemagglutination inhibition properties 
of 9BG5 for virions and ISVPs, a finding that provides additional evidence for a structural 
rearrangement of σ1 during virion-to-ISVP conversion. 
In order to gain insights into the region of σ1 that anchors the protein into the virus 
capsid and to investigate the regions of predicted enhanced flexibility, crystal structures 
of the T1 and T3 σ1 tail domains were solved at high resolution. Both proteins possess a 
heptad repeat pattern of hydrophobic amino acids and form stable trimeric α-helical 
coiled coils. A discontinuity of the heptad repeat is conserved in the serotypes, and with 
our structural investigation we were able to define how the heptad repeat break is 
compensated by the proteins. The structural analysis of a T3 σ1 construct composed of 
the tail and the body domain revealed an unexpectedly seamless transition between the 
two domains. This finding is in contrast to the predicted higher flexibility of σ1 within this 
region and requires a reconsideration of the current model. Sequence analysis indicates 
that the observed interactions that stabilize the tail-body junction of T3 σ1 are conserved 
within the other serotypes. Our investigation of the tail and the tail-body junction of σ1 
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enabled us to formulate a full-length model of the elongated σ1 protein at high-resolution 
and provide a platform for future studies to define the flexibility of this protein. 
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Zusammenfassung 
Die virale Zelladhesion, sowie der darauffolgende Eintritt in die Wirtszelle sind 
Schlüsselschritte einer Virusinfektion, weshalb daran beteiligte virale Proteine häufig Ziel 
neutralisierender Antikörper sind.  
Humane Orthoreoviren (Reoviren) dienen als Modelsysteme zur Erforschung viraler 
Pathogenität, sowie der Wirts-Immunität und sind zudem vielversprechende onkolytische 
Agenzien und Vektoren für Impfstoffe. Das Reovirus-Adhesionsprotein σ1 bindet 
„junctional adhesion molecule-A“ (JAM-A), sowie sialinsäurehaltige Co-Rezeptoren. 
Während des Reovirus-Zelleintritts findet ein säureabhängiger, proteolytischer Abbau zu 
„infektiösen subviralen Partikeln“ (ISVPs) statt. Es wird angenommen, dass das σ1 
Protein dabei eine Strukturänderung durchläuft.  
Diese Arbeit befasst sich mit der strukturellen Analyse von Komplexen zwischen dem σ1 
Protein von Serotyp 1 (T1) bzw. 3 (T3) mit antigen-bindenden Fragmenten (Fabs) der 
serotypspezifischen Antikörper 5C6 bzw. 9BG5. Durch die Strukturaufklärung konnten 
die Epitope bestimmt, und erklärt werden wie Reovirus-Varianten der 
Antikörperneutralisation entgehen können. Mittels Oberflächenplasmon-Resonanz 
Spektroskopie wurde das Bindevermögen von JAM-A gemeinsam mit den Antikörpern 
untersucht, sowie die Affinitäten von JAM-A und Fabs zu σ1 bestimmt. Zusammen mit 
der Analyse von Hämagglutinationshemmtests und Zelladhesionsuntersuchungen 
konnte ein Mechanismus der Antikörper vermittelten Infektionsneutralisierung aufgestellt 
werden. 9BG5 wies deutliche Unterschiede in der Hämagglutinationshemmung zwischen 
Viren und ISVPs auf, was ein weiteres Indiz für die Strukturänderung von σ1 während 
des Übergangs von Viren zu ISVPs darstellt. 
Um Einblicke in die σ1-Region zu erhalten, welche das Protein im Viruskapsid verankert 
und um vorhergesagte Regionen mit erhöhter Flexibilität zu untersuchen, wurden 
Kristallstrukturen mit hoher Auflösung der filamentösen „tail“-Domäne von T1 σ1 und 
T3 σ1 gelöst. Beide Proteine enthalten ein Wiederholungsmuster von hydrophoben 
Aminosäuren und bilden stabile α-helikale Bündel. Eine Diskontinuität im 
Wiederholungsmuster ist bei allen Serotypen konserviert. Anhand der Strukturen konnte 
gezeigt werden wie das σ1 Protein diese kompensiert. 
Die strukturelle Analyse eines T3 σ1 Konstrukts, welches die „tail“- sowie die „body“-
Domäne beinhaltet, zeigt einen unerwartet nahtlosen Übergang der beiden Domänen, 
was im Gegensatz zur vorhergesagten, höheren Flexibilität dieser Proteinregion steht 
und eine Überdenkung des momentanen Models fordert. Sequenzanalysen deuten 
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darauf hin, dass die beobachteten Interaktionen, die den Übergang der „tail“ und der 
„body“-Domäne von T3 σ1 stabilisieren bei den anderen Serotypen ebenfalls konserviert 
sind. Die Untersuchung der „tail“ und der „tail-body“ Konstrukte bieten eine Plattform 
zukünftiger Studien zur  Flexibilitätsuntersuchung des σ1 Proteins und ermöglichten das 
Erstellen eines Modells über die gesamte Proteinlänge.  
 
Contributions of Others 
Hemagglutination inhibition and cell-binding assays that are mentioned in the abstract 
and the discussion section have been performed and are marked as such by Kristen M. 
Ogden. 
The surface plasmon resonance experiment that is shown in figure 4.25B was designed 
and performed together with Kerstin Reiss.  
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Abbreviations 
The commonly used abbreviations for chemical and physical units, amino acids and DNA 
bases are used.   
 
AHTC   Anhydrotetracycline 
Amp   Ampicillin 
APS   Ammonium persulfate 
CAPS   N-cyclohexyl-3-aminopropanesulfonic acid 
cc   Coiled coil 
CD   Circular dichroism 
CDR   Complementarity determining region 
DNA   Deoxyribonucleic acid 
dNTP   2’-deoxynucleotide triphosphate 
dsRNA  Double-stranded ribonucleic acid 
DTT   Dithiothreitol 
DLS   Dynamic light scattering 
E. coli   Escherichia coli 
EDC   1-ethyl-3-(3-dimethylaminopropyl) carbodiimide 
EDTA   Ethylenediaminetetraacetic acid 
EM   Electron microscopy 
Fab   Fragment antigen binding 
FRET   Fluorescence resonance energy transfer 
GdmCl   Guanidine hydrochloride 
HA   Hemagglutination  
HEPES  4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
IgG   Immunoglobulin G 
IgSF   Immunoglobulin superfamily 
IPTG   Isopropyl β-D-1-thiogalactopyranoside 
ISVP   Infectious subvirion particle  
JAM-A   Junctional adhesion molecule-A 
Kan   Kanamycin 
LB   Lysogeny Broth 
mAb   Monoclonal antibody 
MALDI   Matrix-assisted laser desorption ionization 
MES   2-(N-morpholino) ethanesulfonic acid 
MOPS   3-(N-morpholino) propanesulfonic acid 
MPD   2-methyl-2,4-pentanediol 
mRNA   Messenger ribonucleic acid 
NCS   Non-crystallographic symmetry 
NgR1   Nogo receptor 
NHS   N-hydroxysuccinimide 
OD600   Optical density at 600 nm 
ORF   Open reading frame 
P20   Polyoxyethylene sorbitan 
PAGE   Polyacrylamide gel electrophoresis 
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PCR   Polymerase chain reaction 
PDB   Protein data bank 
PEG   Polyethylene glycol 
PMSF   Phenylmethylsulphonyl fluoride 
r.m.s.d.  Root mean square deviation 
RU   Response unit 
SAD   Single anomalous dispersion 
SEC   Size exclusion chromatography 
SDS   Sodium dodecyl sulphate 
SLS   Swiss Light Source 
SPR   Surface plasmon resonance 
T1L   Type 1 Lang 
T2J   Type 2 Jones 
T3D   Type 3 Dearing 
TAE   tris-acetate EDTA 
TEMED  N,N,N’,N’-tetramethylethylenediamine 
TMNO   Trimethylamine N-oxide 
Tris   Tris(hydroxymethyl)aminomethane 
UTR   Untranslated region 
UV   Ultraviolet 
v/v   Volume per volume 
w/v   Weight per volume 
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1 Introduction 
1.1 Reoviridae 
The Reoviridae (respiratory enteric orphan viruses) form a family of non-enveloped, 
icosahedral viruses with a segmented double-stranded RNA (dsRNA) genome. Members 
of the group possess 9-12 dsRNA segments within a single or multi-layered capsid that 
measures 60-85 nm in diameter [1,2]. The family name refers to early virus isolates from 
healthy humans with no enteric and respiratory symptoms of disease [3].  
Currently, 15 different genera are classified and subdivided into turreted and non-turreted 
Reoviridae viruses. Prominent representatives of the non-turreted subspecies are 
Rotavirus and Orbivirus. Rotaviruses cause severe gastroenteritis in infants and young 
children (< 5 years of age) and are a major cause of diarrhea-related hospitalization and 
child mortality in low-income countries [4,5]. Bluetongue virus and African horse sickness 
virus belong to the Orbivirus genus and are economically important pathogens of 
livestock [6].   
Within the turreted subfamily, the Orthoreovirus genus includes viruses that infect 
mammals, birds and reptiles. Mammalian orthoreoviruses (herein referred to as 
reoviruses) are geographically widespread and infect virtually all mammals. Three major 
reovirus serotypes have been described, which can be differentiated through 
neutralization and hemagglutination inhibition tests [3,7]. Each serotype is represented 
by a prototype strain isolated from a human host: type 1 Lang (T1L), type 2 Jones (T2J), 
and type 3 Dearing (T3D).  
Reovirus infection is mainly asymptotic in humans and can lead to mild respiratory and 
gastrointestinal disease symptoms in infants. In contrast, newborn mice are highly 
sensitive to reovirus infection, display serotype-specific disease patterns, and serve as 
model systems to study reovirus-host interactions and pathogenesis [8-10]. Reoviruses 
are prototypic members of the Reoviridae and, as they induce cell death and apoptosis 
preferentially in tumor cells, they are currently being tested as oncolytic agents in clinical 
trials [11]. 
 
1.1.1 Mammalian Orthoreovirus Structure and Components 
Reoviruses encapsidate 10 dsRNA segments within a double-layered icosahedral protein 
shell. The ten genome segments are grouped and named according to their 
electrophoretic mobility into large (L1-L3), medium (M1-M3), and small (S1-S4) 
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segments. With exception of the bicistronic S1 gene, each gene segment is monocistronic 
and, thus, a total of eleven proteins (eight structural and three non-structural proteins) 
are encoded by the genome. The viral proteins are designated with the Greek letters λ, 
μ, and σ, in reference to their size class. The structural proteins are additionally 
numbered according to their relative electrophoretic mobility. As the size of the gene 
segments does not strictly correlate with the protein size there are some differences in 
the gene and protein nomenclature (Figure 1.1). 
 
 
Figure 1.1 Reovirus capsid organization. (A) Schematic representation of the reovirus particle. The 
viral capsid proteins are labeled. (B) The genome segments and their corresponding protein products 
are listed. Eight structural and three non-structural proteins (µNS, σNS, and σ1s) are encoded by the 
reovirus genome. The protein components of the inner and outer capsid with the copy number per 
particle are indicated. Adapted from ViralZone (www.expasy.org/viralzone, Swiss Institute of 
Bioinformatics). 
 
The inner core of the virus capsid exhibits icosahedral T=1 symmetry formed by 60 
dimers of λ1. The intersubunit contacts of λ1, reveal a high degree of non-equivalency 
[12]. Four additional viral proteins (σ2, λ2, λ3, and μ2) also contribute to core formation. 
The 150 σ2 monomers bridge the λ1 subunits and stabilize the core from the outside. At 
each five-fold axis, a pentameric λ2 protein, which is the RNA-capping enzyme, forms a 
large turret that also protrudes from the outer capsid. The monomeric RNA-dependent 
RNA polymerase λ3 is located at the inner surface of each five-fold vertex and faces a 
small channel leading through the λ1 shell [13]. Approximately 12-24 copies of μ2, which 
dsRNA 
segment 
Encoded 
protein 
Location 
(capsid) 
Copy 
number 
L1 λ3 Inner 12 
L2 λ2 Inner 
Outer  
60 
L3 λ1 Inner 120 
M1 μ2 Inner 12-24 
M2 μ1 Outer 600 
M3 μNS - - 
S1 σ1 
σ1s 
Outer 
- 
36 
- 
S2 σ2 Inner 150 
S3 σNS - - 
S4 σ3 Outer 600 
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has an influence on the transcriptase and nucleoside triphosphatase activity of the core, 
are present [14].  
The outer capsid is arranged with icosahedral quasi T=13 (laevo) symmetry and is 
primarily composed of 200 heterohexamers of μ1 and σ3. The µ1 protein is the 
membrane-penetration molecule and is protected from the environment by σ3, which 
forms finger-like projections on the virus surface. Most of the µ1 protein is 
autocatalytically cleaved and present as two fragments, µ1N and µ1C. At each five-fold 
axis, the trimeric reovirus attachment protein σ1 anchors into a λ2 pentamer. The σ1 
protein is a filamentous molecule that uses proteinaceous and carbohydrate receptors to 
engage host cell surfaces [15-18]. σ1 of all reovirus serotypes binds to junctional 
adhesion molecule A (JAM-A), an integral component of intercellular tight junctions. σ1 
also binds cell-surface carbohydrates, but the serotypes differ in the location of the 
binding site and carbohydrate specificity [17,19].  
 
1.1.2 Entry Pathway and Replication Cycle 
Reovirus attachment to target cells is thought to occur via a two-step adhesion 
strengthening mechanism. Low-affinity binding to carbohydrate receptors enables the 
virus to diffuse laterally on the cell surface and allows access and high-affinity binding to 
JAM-A [20].  
Reovirus is internalized via receptor-mediated endocytosis, which involves β1-integrin 
binding probably to integrin-recognition sequences (RGD or KGE) in the λ2 protein 
[21,22]. The endocytic vesicles are then transported along microtubules and accumulate 
in late endosomes, where the viral outer-capsid undergoes stepwise, acid-dependent 
proteolysis (Figure 1.2) [23-25]. Reovirus uncoating is catalyzed by cathepsin proteases 
B, L, and S and leads to an initial disassembly intermediate termed infectious subvirion 
particle (ISVP) [26,27]. ISVPs are characterized by the removal of σ3, cleavage of μ1C 
into particle-associated fragments δ and φ, and a conformational change in the σ1 
protein, from a compact to an elongated structure [28,29]. ISVPs also can be generated 
by proteases (chymotrypsin and trypsin) in the intestinal lumen after peroral inoculation, 
and they can be internalized either by endocytosis or by direct penetration of the plasma 
membrane [30-35].  
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Figure 1.2 Reovirus cell entry and replication cycle. Reovirus engages carbohydrate receptors and 
junctional adhesion molecule A (JAM-A) using an adhesion strengthening mechanism. The virions 
enter the cell by receptor-mediated endocytosis (1). Within late endosomes the virions are first 
converted to infectious subvirial particles (ISVP) (2). ISVPs can also be generated by proteases in the 
intestinal lumen and internalize either by endocytosis (A) or by direct penetration of the cell membrane 
(B). ISVPs in the endosomal compartment are processed into ISVP*s by rearranging µ1 fragments to 
expose hydrophobic residues and by the release of σ1 and µ1N (3). The µ1 fragments mediate 
penetration of the endosomal membrane that leads to the release of transcriptionally active core 
particles into the cytoplasm (4). Viral mRNA is synthesized, exported into the cytoplasm and translated 
by ribosomes into viral proteins. Large inclusions (viral factories) develop, where progeny reoviruses 
assemble (5). Mature virions are formed (6) and released upon cell lysis (7). 
 
Endosomal ISVPs are further processed into ISVP*s, the second disassembly 
intermediate. In ISVP*s, the µ1-fragments undergo conformational rearrangements 
exposing hydrophobic residues, and µ1N and the σ1 protein are released from the 
particle [36,37]. Penetration of the endosomal membrane is mediated by the µ1 cleavage 
fragments. This leads to the release of transcriptionally active core particles into the 
cytoplasm (Figure 1.2) [38].  
The core uses ribonucleoside triphosphates and S-adenosyl-L-methionine from the host 
cell to transcribe mRNAs from the (-)RNA of the reovirus genome segments. The newly 
synthesized (+)RNAs lack 3’ polyadenylation, are 5’ capped, and are delivered into the 
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cytoplasm through the central cavity of the λ2 turrets. These viral RNAs are translated by 
ribosomes, and upon encapsidation into core particles they also serve as templates for 
the synthesis of new dsRNA [39].  
Reovirus replication and assembly takes place in cytoplasmic viral inclusions. Their 
formation is mainly regulated by the nonstructural proteins µNS and σNS and the 
structural protein µ2. In these inclusions, viral proteins, RNA, nascent and complete 
particles, and components of the cell cytoskeleton are concentrated [2]. Mature reovirus 
virions are formed by the assembly of the outer capsid around the nascent core particles 
and are released, presumably following reovirus-induced cell death and disruption of the 
host cell membrane [40,41].  
 
1.1.3 Reoviruses as Cancer Therapeutics 
Reoviruses are promising anti-cancer agents as they preferentially target and replicate 
within tumor cells and cause oncolysis. Their effect on certain transformed cell lines was 
first described in 1977 [42,43]. Currently, there are more than 30 completed and ongoing 
clinical trials (including phase I-III studies) focusing on reovirus T3D (Reolysin®, 
Oncolytics Biotech) as a cancer therapeutic.  
Reovirus is well tolerated with low virulence and shows significant anti-cancer efficacy for 
many human tumor types in patients. Reovirus takes advantage of abnormal Ras 
activation in cancer cells, but the role of the Ras pathway for reovirus selective oncolysis 
is poorly understood and requires further investigation [44-46]. Other factors, such as the 
over-expression of reovirus carbohydrate receptors on cancer cells, also may contribute 
to enhanced reovirus infection [47,48]. Reovirus can presumably induce tumor cell death 
through multiple mechanisms, including apoptosis, autophagy, and necrosis [49-51].  
To improve reovirus potency as an anticancer therapeutic, a better understanding of the 
mechanisms underlying its oncolytic activity is crucial. Further attempts seek to 
manipulate host immune responses to selectively reduce reovirus immune-clearance and 
to enhance viral anti-tumor immunity. The efficacy of reovirus oncolysis may also be 
improved by the development of new vectors using the reovirus reverse genetic system 
[52]. 
 
1.2 Reovirus Attachment Protein σ1 
The three reovirus serotypes differ in neutralization and hemagglutination properties and 
invade the central nervous system of newborn mice by different routes and cause 
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serotype-specific patterns of disease. From the murine intestine, T1L spreads 
hematogenously, infects ependymal cells, and causes non-lethal hydrocephalus. In 
contrast, T3D spreads via hematogenous and neural routes, infects neurons, and causes 
lethal encephalitis [8,9,53,54]. Oral inoculation of T2J leads to nonlethal encephalitis, but 
as T2J is difficult to cultivate, the pathogenesis of this reovirus strain is poorly understood 
[55,56]. Studies using reassortant reoviruses indicate that the serotype-dependent 
differences are linked to the S1 gene segment [57,58]. 
The S1 gene possess two open reading frames; the first encodes the attachment protein 
σ1, and the second the small nonstructural protein σ1s. In comparison to the other gene 
segments, which are highly similar among the reovirus serotypes, the S1 genes are more 
divergent [59].  
The σ1 proteins of T1L and T2J are more closely related to each other (with 49% 
sequence identity) than to T3D σ1 (26% and 27% identity, respectively) [60]. Just about 
10% of the amino acids are conserved in the σ1 proteins of all three serotypes. 
Therefore, it is not surprising that the outer-capsid protein σ1 is a major determinant of 
serotype-specific differences in spread and tropism, and it is also a main target of the 
serotype-specific neutralizing antibody response.  
 
1.2.1 Domain Organization and Structure 
The trimeric attachment protein σ1 is a filamentous molecule of about 480 Å in length 
[29,61]. Amino acid sequence analyses predicted that σ1 consists of distinct domains, 
termed tail, body, and head, an organization that is conserved between the different 
serotypes (Figure 1.3) [60]. 
EM reconstructions of reovirus virions and ISVPs indicate that σ1 assumes a more 
compact conformation on virions, while it extends as an elongated structure from ISVPs. 
This observation suggests that σ1 undergoes an extensive structural rearrangement 
during virion-to-ISVP conversion [28,29]. EM images of σ1 isolated from virions show 
higher flexibility at a region near the N-terminus, at the midpoint of the molecule 
coinciding with the junction of the tail and body domains, and a region near the head 
domain [61]. The length and flexibility of the σ1 protein are important for its function [62]. 
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Figure 1.3 Conserved domain organization of the σ1 protein. Model of the secondary structure. 
Three structurally and functionally distinct domains of σ1 termed tail, body, and head are indicated. 
The first 20-25 residues of the N-terminus anchors the protein into the virus particle and harbors a 
short heptad repeat pattern of hydrophobic amino acids that predict an α-helical coiled coil. The small 
coiled coil is separated by a few residues from a predicted longer coiled coil that comprises most of 
the remaining tail. Structural information is available for the body and the head domain [17,19,63]. The 
body domain consists mostly of β-spiral repeats, interrupted by a small coiled coil segment. The C-
terminal part of the molecule forms a globular head domain.  
 
Tail Domain 
The first 20-25 N-terminal amino acids of σ1 anchors the protein into the pentameric 
turrets of λ2 at the icosahedral vertices. The three-fold symmetry of σ1 does not match 
the five-fold symmetry of λ2. Such symmetry mismatches are rare and are found at the 
head-tail junctions of bacteriophages, in polyomavirus VP1/VP2 interactions and 
adenovirus fiber-penton complexes [64-66]. Symmetry mismatches are linked to 
interactions of limited strength or specificity [67]. Furthermore, proteins involved in 
symmetry mismatches often undergo structural changes. The possible weak connection 
between σ1 and λ2 might play a role during reovirus disassembly. σ1 is assumed to 
rearrange its structure during virion-to-ISVP conversion, and it is released from the 
particle during transition from ISVPs to cores. This later step also involves a structural 
rearrangement in λ2 and enables nascent mRNA to exit the particle at the five-fold 
symmetry axis, where σ1 was anchored [28]. 
A small region of the N-terminus and most of the remaining tail domain of σ1 exhibit a 
heptad repeat pattern of hydrophobic amino acids that predict the formation of an α-
helical coiled coil [60,61]. Usually, this structural motif (abcdefg)n possesses hydrophobic 
amino acids at positions a and d, whereas the other positions are occupied by more 
polar residues (Figure 1.4). Within a helical bundle a hydrophobic core is formed. The 
core-flanking residues (g and e) often carry charged amino acids that contribute to the 
stability of the structure via interhelical salt bridges [68].  
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Coiled coils are very common structural motifs and usually consist of two, three, or four 
helices. The oligomeric state of coiled coils is determined by core packing interactions, 
as in different multimers the geometry of side chains at positions a and d systematically 
differs. Two-stranded coiled coils prefer β-branched residues (e.g., Ile, Val) at position a 
and unbranched or γ-branched ones (e.g., Leu) at position d. The reverse case is 
favored by four-stranded helical bundles. Trimeric coiled coils have a more uniform side 
chain geometry at these positions [68].  
Protein sequences that follow the heptad repeat pattern wind into left-handed helical 
bundles. Due to this supercoiling, the number of residues per turns is reduced to 3.5 in 
comparison to undistorted α-helices. This allows the realization of periodically equivalent 
positions along the bundle. Discontinuities in the heptad repeat pattern, such as 
insertions of one (skip), three (stammer), or four (stutter) amino acids, are frequently 
encountered in coiled coil structures. Such discontinuities can be tolerated within a 
continuous coiled coil but account for a local distortion of the geometry [69].  
 
 
Figure 1.4 Helical wheel representation of a three-stranded α-helical coiled coil. (A) The heptad 
repeat pattern (abcdefg)n harbors hydrophobic amino acids (H) at positions a and d that point towards 
the inside of the helical bundle. The remaining positions are usually occupied by polar residues (P). 
The e and g positions often carry charged amino acids that can form electrostatic interactions with the 
adjacent α-helices. (B) A stutter is a four-residue insertion in the heptad repeat, a discontinuity that 
leads to a local distortion of the coiled coil geometry. The insertion raises the local sequence 
periodicity and causes an unwinding of the coiled coil that alters the relative position of the residues. 
This is schematically shown as a rotation of the helices. Typical a and d positions of undistorted coiled 
coils are shown in the upper row. Stutters shift position a residues (dark red) toward the core center 
leading to a so-called x layer. Position d residues (light red) are shifted out of the core and the 
following residues move towards position a, leading to a da layer. Depending on whether the insertion 
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occurs close to a core position or between the core positions, one or two consecutive layers are 
distorted. Adapted from [68]. 
In the repeating pattern of the σ1 tail two discontinuities are predicted; a stutter and a 
skip [60]. Following the stutter, the location of which is conserved in all three serotypes, 
T1L has a 14-residue and T2J a 7-residue insertion relative to T3D σ1. Therefore, it is 
assumed that the long α-helical coiled coil of T1L σ1 consists of 22.5, T2J σ1 of 21.5, 
and T3D σ1 of 21 heptads. In all cases, the skip is predicted at the C-terminal end of the 
coiled coil at the boundary between the tail and body domains [60].  
 
Body Domain 
The body domain consists mostly of triple β-spiral repeats, a fold thus far observed only 
in a small number of viral fiber proteins, including the adenovirus fiber, the avian reovirus 
sigma C protein, and the bacteriophage PRD1 [70-72]. The β-spiral repeat motif is 
characterized by a consensus sequence (a-o) with conserved apolar residues (at 
positions c, e, g, k, m) and either a proline or glycine at position j. Each repeat is 
composed of two short anti-parallel β-strands, which are connected by a four-residue β-
turn with a proline or glycine at the third position. The following repeat is connected with 
a surface-exposed loop.  
For T3D σ1, structural information for the complete body and head domain is available 
[19]. The T3D σ1 body consists of seven triple β-spiral repeats (β1-β7) and a short α-
helical coiled coil segment that is incorporated between β-spiral repeats β4 and β5 
(Figure 1.5). T3D σ1 is sensitive to protease cleavage within the body domain. Trypsin 
cleaves after R245, while chymotrypsin cleaves after L261 and F239 [73]. T3 field 
isolates that exhibit a single polymorphism, T249I, which is located at a d position of the 
short coiled coil of the body domain, are resistant to trypsin cleavage [74]. This indicates 
that an intact heptad repeat is required to resist cleavage at a nearby site. The glycan-
binding site of T3D σ1 is also located in the body domain, between β-spiral repeats β2 
and β3 [19]. 
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Figure 1.5 Crystal structures of T1L σ1 and T3D σ1. (A, B) Ribbon drawing of crystal structures 
that provide the most complete picture of T1L σ1 and T3D σ1 available up to date. The trimeric 
molecules are colored in blue, red and yellow. (A) T3D σ1 body and head domains (residues 170-455, 
PDB ID: 3S6X). The body consists of seven triple β-spiral repeats (β1-β7) and a small coiled coil (cc) 
inserted between β4 and β5. The globular head folds into a β-barrel formed by two Greek-key motifs. 
(B) T1L σ1 structure of the last three β-spiral repeats and the globular head domain (residues 265-
470, PDB ID: 4GU3).  
 
The sequences of T1L and T2J σ1 also possess a small heptad repeat pattern (of two 
full turns) within the body domain. Like T3D σ1, there are an arginine and a glutamate at 
predicted g and e positions that could stabilize the potential coiled coils with electrostatic 
interactions [60]. However, since a proline residue is observed in the consensus 
sequence in both cases, it is uncertain if these proteins also exhibit a small α-helical 
coiled coil at the equivalent position of T3D σ1 [19]. 
Currently, there is no structural information available for T2J σ1. For T1L σ1, the most 
complete X-ray structure (at 3.5 Å) comprises the head and the three most C-terminal β-
spiral repeats (Figure 1.5) [17]. In both T1L and T3D σ1, the transition from the body to 
the head domain contains a flexible region that allows movement between the two 
domains. The observed linker region fits well with the region of higher flexibility near the 
head domain that has been predicted from electron micrographs [63].  
 
Head Domain 
The C-terminal one third of the σ1 molecule folds into two Greek-key motifs (β-strands A-
D and β-strands E-H) that assemble into a β-barrel forming the globular head domain 
[63]. Apart from the D-E-loop, which contains a 310-helix, the other β-strand connecting 
loops are short. The head harbors an unusual aspartic acid cluster that is located at the 
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lower, N-terminal part of the head and stabilizes the trimer. This arrangement may be 
involved in a conformational change upon exposure of the molecule to low pH [75]. 
The σ1 head domain binds to the serotype-independent receptor JAM-A, and in the case 
of T1L σ1, it can additionally bind to glycan receptors. Two serotype-specific neutralizing 
antibodies, 5C6 and 9BG5, which target the σ1 protein of T1 and T3, respectively, also 
engage the head domain. 
 
1.2.2 Receptor Interactions 
The σ1 protein specifically interacts with host cell receptors and is therefore a major 
determinant of virus cell selection, spread, and tropism.  
 
Interactions with JAM-A 
All reovirus serotypes use JAM-A as a cellular receptor [15]. The JAM-A molecule 
belongs to the immunoglobulin superfamily (IgSF) and is localized at tight junctions of 
endothelial and epithelial cells and is also expressed on leukocytes and platelets. JAM-A 
plays a role in the regulation of epithelial cell polarity, leukocyte transmigration, and in 
the stabilization of the blood-brain barrier [76].  
The JAM-A molecule is composed of two extracellular Ig-like domains termed D1 and 
D2, a single transmembrane region, and a short cytoplasmic tail. JAM-A forms 
homodimers via mostly ionic interactions between the membrane-distal, N-terminal D1 
domains [77,78].  
The 3.4 Å resolution structure of the T3D σ1 head domain in complex with human JAM-A 
D1 provided detailed insights into σ1 receptor recognition [79]. The lower part of the σ1 
head binds to JAM-A at the site that is also involved in JAM-A homodimer formation. The 
receptor binding site on σ1 comprises the 310-helix in the D-E-loop and at the head-body 
transition the most C-terminal β-spiral repeat and a short α-helix. Each σ1 monomer of 
the trimeric head is ligated by one JAM-A molecule (Figure 1.6). As the affinity of JAM-A 
for σ1 is higher than the affinity of JAM-A for itself, binding of JAM-A by σ1 leads to the 
separation of the JAM-A homodimer [80].  
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Figure 1.6 Crystal structure of T3D σ1 in complex with human JAM-A D1. Cartoon representation 
of the complex (PDB ID: 3EOY). The σ1 head is colored in blue, red and yellow, and JAM-A D1 is 
colored in green. (A) View along the threefold axis. (B) View perpendicular to the threefold axis. 
Modified from [79].  
 
JAM-A engagement by σ1 is required for reovirus hematogenous dissemination from the 
site of primary replication [81]. Residues involved in JAM-A binding are conserved 
among the reovirus serotypes. Thus, the σ1 molecules of T1L, T3D, and probably T2J 
engage JAM-A in a similar manner and make the recognition of JAM-A unlikely to be 
responsible for differences in pathogenesis [82]. When JAM-A-deficient mice are 
inoculated intracranially, with T1L and T3D, the distinct patterns of tropism in the CNS 
are maintained. Therefore, the serotype-specific differences, which segregate with the 
S1 gene, can be best attributed to σ1 engagement of cell-surface receptors other than 
JAM-A. 
The Nogo receptor (NgR1) serves as a receptor for reovirus infection of neurons [16]. 
Virions but not ISVPs are able to engage NgR1. This finding indicates that either σ3, 
which is lost during virion-to-ISVP conversion, or a specific virus-associated σ1 
conformation mediates NgR1 binding. Both T1 and T3 strains can infect non-neuronal 
cells that express NgR1 [16]. Studies using reassortant viruses show that those viruses 
that differ only in the σ1 proteins have similar binding affinities for NgR1, while T1L 
displays a greater affinity for NgR1 compared to T3D (Dermody, unpublished). Thus, σ3 
is more likely the reovirus ligand for NgR1. These findings suggest a model in which σ1 
facilitates binding to target cells in the CNS by engagement of cell-surface glycans, and 
σ3 then mediates entry into neurons by binding to NgR1. 
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Interactions with Carbohydrate Receptors 
Sialic acid-containing glycans are present on cell surfaces of all vertebrates and some 
invertebrates and are involved in numerous functions, including self-recognition, cell-cell 
adhesion, extrinsic and intrinsic signaling. They moreover serve as receptors for a variety 
of viruses [83].   
Sialic acid is commonly found as a terminal monosaccharide connected by α(2,3)- or 
α(2,6)- linkage to various carbohydrates or by an α(2,8)-linkage to another sialic acid 
[84]. The underlying glycan chains can vary widely in composition and length and can be 
linked to proteins or lipids, creating a large number of diverse sialylated glycan 
structures. Virus-sialic acid interactions are typically of low affinity and are amplified by 
the multivalency of binding sites present on the virus surface [20,85].  
The reovirus serotypes engage sialic acid using different parts of the σ1 molecule and 
have different hemagglutination profiles [17,19,86,87]. T1L specifically binds to both 
terminal carbohydrate portions of the ganglioside GM2 using a small cleft in the σ1 head 
domain [17].  In contrast, T3D binds a range of differently linked sialylated glycans near 
the N-terminal part of the σ1 body domain (Figure 1.7).  
 
 
Figure 1.7 Glycan binding sites of T1L σ1 and T3D σ1. Ribbon drawing of the σ1 trimer colored in 
blue, red, and yellow. Carbohydrates are shown in black. A schematic σ1 molecule is shown in the 
middle and indicates the location of the carbohydrate binding sites on T1L σ1 and T3D σ1, 
respectively. (A) T1L σ1 binds to the glycan moiety of the ganglioside GM2 in the head domain. (PDB 
ID: 4GU3). Both terminal carbohydrates of the GM2 glycan contact σ1. Most interactions are formed 
between sialic acid (black circle) and backbone atoms of the protein. (B) The glycan binding site of 
T3D σ1 is located in the body domain in a loop region connecting β-spiral repeat β2 and β3. The 
terminal sialic acid of α(2,3)-sialyllactose (3’SL) mostly contributes to interactions with σ1. 
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Crystal structures of T3D σ1 in complex with α(2,3)-sialylactose, α(2,6)-sialyllactose, and 
α(2,8)-disialyllactose elucidated the carbohydrate binding site at a loop connecting β-
spiral repeats β2 and β3 [19]. In each complex structure, the terminal sialic acid 
contributes mostly to contacts with σ1. In newborn mice, the neurovirulence of wildtype 
T3D is greater in comparison to a mutant virus that lacks the capacity to bind sialic acid, 
indicating that carbohydrate receptor binding has an influence on reovirus pathogenesis 
[88]. 
 
Target of Neutralizing Antibodies 
The reovirus-induced neutralizing antibody response is mainly directed against the σ1 
protein [89]. Monoclonal antibodies (mAbs) that target σ1 have been used to identify 
distinct functional domains of the σ1 protein [90]. 
The mouse IgG2a mAbs 5C6 and 9BG5 target σ1 of T1 and T3 reovirus, respectively, 
and their neutralization capacity has been demonstrated by classical plaque-reduction 
neutralization experiments [90-93]. Cross-reactivity of both mAbs with the non-cognate 
σ1 protein occurs [94-96]. Both mAbs are highly effective in vivo at protecting neonatal 
mice from reovirus-induced disease [91,94]. 5C6 and 9BG5 inhibit virus-induced 
hemagglutination (HA), although HA inhibition by 9BG5 is not always observed 
[90,91,96,97]. Sequence-analysis of reovirus escape mutants identified specific residues 
in the σ1 head domain that are required for efficient neutralization by 5C6 and 9BG5 
[92,98], but the precise binding epitopes and mechanisms of neutralization by these 
antibodies are unknown. 
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2 Objectives 
The structural investigation of the reovirus attachment protein σ1 and its interaction with 
neutralizing mAbs is the focus of the present thesis. The reovirus σ1 protein binds host 
cell-receptors, is a major target of the neutralizing antibody response, and is assumed to 
undergo a conformational change during the reovirus cell entry process.  
Interactions between σ1 and cell-receptors (glycans and JAM-A) are well understood, 
while less is known about how neutralizing mAbs engage σ1 and inhibit reovirus 
infection. To date, only limited information exists about the conformational change of σ1. 
It is assumed that flexible regions predicted within the molecule are involved in the 
structural rearrangement. At the beginning of this study, structural detail at high 
resolution was available for parts of the σ1 molecule (for the body and the head domain 
of T3 σ1, for small regions of the tail, parts of the body and the head domain of T1 σ1), 
but not for the tail of T3 σ1 or the connection of the tail and the body domain. The major 
objectives of this thesis were to: 
 
 identify the complete epitope of the serotype-specific mAbs 5C6 and 9BG5 
 define the interactions of these mAb with σ1 on a structural basis to obtain 
insights about the mechanism of neutralization 
 identify how reovirus variants escape mAb 5C6 and 9BG5 neutralization 
 determine affinities and kinetics for the binding of σ1 with 5C6 and 9BG5 Fabs 
 determine affinities of σ1 for the serotype-independent receptor JAM-A 
 solve the structure of the σ1 tail domain 
 obtain information about flexible regions within the fibrous part of the σ1 molecule 
to gain insight into the proposed structural change 
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3 Materials and Methods 
3.1 Chemicals 
All chemicals used in this work were of analytical reagent grade and obtained from: 
Roth (Karlsruhe, Germany), Sigma-Aldrich (Deisendorf, Germany), Merk (Darmstadt, 
Germany), GE Healthcare (Uppsala, Sweden) and Hampton research (Aliso Viejo, USA). 
 
3.2 Bacterial Strains 
The Escherichia coli (E. coli) strain XL 10 gold (Stratagene, USA) was used for 
amplifying plasmid-DNA. Proteins were produced in E. coli BL21 (DE3) or Rosetta 2 
(DE3) strains (Novagen, Darmstadt, Germany).  
 
E. coli strain Genotypes 
XL 10 gold TetRΔ(mcrA)183Δ(mcrCB-hsdSMR-mrr)173 endA1 supE44 thi-1 recA1 
gyrA96 relA1 lac Hte [F´ proAB lacIqZΔM15 Tn10 (TetR)  (KanR) Amy] 
BL21 (DE3) F- ompT hsdSB(rB- mB-) gal dcm (DE3) 
Rosetta 2 (DE3) F- ompT hsdSB(rB- mB-) gal dcm (DE3) pRARE2 (CamR) 
 
3.3 Plasmids 
Plasmid Resistence Specifications Origin 
pET15b Amp T7 promotor, N-terminal His6-tag, thrombin 
cleavage site, MCS 
Novagen, 
Germany 
pET16b Amp T7 promotor, N-terminal His6-tag, Factor 
Xa cleavage site, MCS 
Novagen, 
Germany 
pET28b Kan T7 promotor, N-terminal His6-tag, thrombin 
cleavage site, MCS, C-terminal His6-tag 
Novagen, 
Germany 
pE-SUMOpro Amp T7 promotor, N-terminal His6-Smt3-tag, 
UlpI cleavage site 
LifeSensors, 
USA 
pBacPAK Amp T7 promotor Addgene, UK 
pIBA-GCN4tri Amp tet promotor, N-and C-terminal GCN4tri, 
C-terminal His6-tag  
Dirk Linke, 
MPI Tübingen 
 
3.4 Primers 
Primers were bought from biomers.net (Ulm, Germany) or for sequencing from Eurofins 
Genomics (Ebersberg, Germany). 
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Primer Sequence 
Cloning primer  
T1L σ1(2-470)for CAGGTCTCCAGGTGATGCATCTCTCATTACAGAGATACG (BsaI) 
T1L σ1(29-470)for CGCGCGCATATGGAGGAAATCAAGAAACAAGTCC (NdeI) 
CGCGCGCATATGGAGGAAATCAAGAAACAAGTCC (NcoI) 
CAGGTCTCCAGGTGAGGAAATCAAGAAACAAGTCCAG (BsaI) 
T1L σ1 (2/29-470)rev GCGGGATCCTACCTCACATTGCATGGATACATGATCGTC (BamHI) 
GCTCTAGATTACCTCACATTGCATGGATACATGATCGTCC (XbaI) 
T1L σ1(29-159)for CGACCCATGGCAGAGGAAATCAAGAAACAAGTCCAG (NcoI) 
T1L σ1(29-159)rev GGTTACAAGGTTAGATGGTCTAATCAATTAGGATCCCGC (BamHI) 
T3D σ1(28-455)for CATTAGCTAGCCTTGAATCAAGGGTCTCGGCGCTCGAG (NheI) 
T3D σ1(30-455)for ATAATCTCGAGTCAAGGGTCTCGGCGCTCGAGAAGAC (XhoI) 
CATAGCTAGCAGGGTCTCGGCGCTCGAGAAGAC (NheI) 
T3D σ1(28/30-455)rev GATGGATCCTACGTGAAACTACGCGGGTACGAAACG (BamHI) 
GATGCTCGAGCTACGTGAAACTACGCGGGTACGAAAC (XhoI) 
T3D σ1(1-xxx)for 
xxx = 234/ 251/ 291 
CATAGCTAGCATGGATCCTCGCCTACGTGAAGAAG (NheI) 
T3D σ1(25-xxx)for 
xxx = 234/ 251/ 291 
CATAGCTAGCTCAAAAGGGCTTGAATCAAGGGTCTCG (NheI) 
T3D σ1(1/25-234)rev GGCCGAAGCTTCTAGAGAGTCAAGTTATTATTAACTATCTGG (HindIII) 
T3D σ1(1/25-254)rev GCTGAAGCTTCTATTGCTCAGTTGCGCCTATCCTTG (HindIII) 
T3D σ1(1/25-291)rev GCTGAAGCTTCTACGATCTAACAGTTAGCTGTCCACTAG (HindIII) 
  
Mutagenesis primer  
T1L σ1(2-117/stop)for CAGTCTGGATACGTAAACGTCTAATCTC 
T1L σ1(2-117/stop)rev GAGATTAGACGTTTACGTATCCAGACTG 
T1L σ1(2-178/stop)for GGAGACGTCTTAGGTGACGACGG 
T1L σ1(2-178/stop)rev CCGTCGTCACCTAAGACGTCTCC 
T1L σ1(29-249/stop)for GGAGAGATTACATTGGTGAGTTAAATCAATGAATTGCC 
T1L σ1(29-249/stop)rev GGCAATTCATTGATTTAACTCACCAATGTAATCTCTCC 
T1L σ1(29-264/stop)for CACTGGAATCAGCGTAAATCGATTCAGTTTTACC 
T1L σ1(29-264/stop)rev GGTAAAACTGAATCGATTTACGCTGATTCCAGTG 
T1L σ1(29-303/stop)for CTGTCGTTACGGTGACGTTTGACTCTTCCGACATACAGG 
T1L σ1(29-303/stop)rev CCTGTATGTCGGAAGAGTCAAACGTCACCGTAACGACAG 
T3D σ1(N182A)for CTCTCAATCCGTAATGCCCGTATGACCATGG 
T3D σ1(N182A)rev CCATGGTCATACGGGCATTACGGATTGAGAG 
T3D σ1(R161A)for GGATTTCGAATCTGCGATATCCACATTAGAGC 
T3D σ1(R161A)rev GCTCTAATGTGGATATCGCAGATTCGAAATCC 
T3D σ1(Q155V)for CGAGTAACATCCATAGTAGCGGATTTCGAATC 
T3D σ1(Q155V)rev GATTCGAAATCCGCTACTATGGATGTTACTCG 
T3D σ1_ΔVTSIfor GACGTTACGAGTAGCGGATTTCGAATCTAGGATATCCACATTAGAG 
T3D σ1_ΔVTSIrev CCGCTACTCGTAACGTCAGAGTTGATAGCTCGGTGGTCAATG 
T3D σ1(154+QST)for CGAGTAACATCCATACAGAGTACAGTAGCGGATTTCGAATCTAG 
T3D σ1(154+QST)rev CTGTATGGATGTTACTCGTAACGTCAGAGTTGATAGCTCG 
T3D σ1(1-168/stop)for CACATTAGAGCGCACGTAGGTCACTAGCGCG 
T3D σ1(1-168/stop)rev CGCGCTAGTGACCTACGTGCGCTCTAATGTG 
  
Sequencing primer  
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T7 for TAATACGACTCACTATAGGG 
T7 term CTAGTTATTGCTCAGCGGT 
 
3.5 Commercial Crystallization Screens 
Screen Company 
Crystal Screens I, II  Hampton research, Aliso Viejo, USA 
Wizard I, II, III, IV  Emerald BioSystems, Bainbridge Island, USA 
JCSG Molecular Dimensions, Suffolk, UK 
PEG ION Hampton research, Aliso Viejo, USA 
Additive screen Hampton research, Aliso Viejo, USA 
 
3.6 Molecular Biology 
3.6.1 Glycerol Stocks 
E. coli culture glycerol stocks were prepared by mixing 900 µl of a bacterial overnight 
culture with 300 µl sterile glycerol solution (50% v/v). The solutions were flash frozen with 
liquid nitrogen and stored at -80°C. 
 
3.6.2 Purification of Plasmid DNA 
Plasmid DNA from E. coli cultures was isolated using a miniprep kit (Promega, 
Mannheim, Germany) according to the manufacturer’s protocol. The DNA concentration 
was determined via absorbance at a wavelength of 260 nm (NanoDrop ND-1000, 
Thermo Scientific, Waltham, USA). 
 
3.6.3 Polymerase Chain Reaction (PCR)  
Polymerase chain reactions (PCR) were performed to amplify DNA. In each case, 50 µl 
total reaction volume was prepared with 100 ng of template DNA, 200 µM dNTPs, 
200 nM primers and 5 U ReproFast DNA-polymerase (Genaxxon bioscience, Ulm, 
Germany). The annealing temperature (TA) of the reaction was selected to be 10-15°C 
below the primer melting temperature and the time for the elongation step (at 72°C) was 
calculated based on the length of the desired insert (1 min per 1 kb).  
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PCR Program: 
1. 1x 94°C 2-7 min 
2. 30x 94°C 1 min 
  TA°C 45 s 
  72°C 30-90 s 
3. 1x 4°C 1-8 h 
 
3.6.4 Site-directed Mutagenesis 
The GENEART® site-directed mutagenesis kit (Life Technologies, USA) was used to 
introduce base substitutions, insertions of 9, or deletions of 12 nucleotides into DNA 
plasmids following the manufacturers’ protocol. The annealing temperature (TA) of the 
reaction was selected to be 10-15°C below the primer melting temperature and the time 
for the elongation step (at 68°C) was calculated based on the length of the plasmid (30 s 
per 1 kb).  
 
3.6.5 Agarose Gel Electrophoresis 
Agarose gel electrophoresis was used to analyze and purify the PCR reaction products. 
0.3 g agarose was dissolved in 30 ml TAE buffer by heating. Prior to gelation 3 µl 
GelRed (Biotium Inc, Fremont, USA) were added. Marker (O´GeneRuler 1kb DNA 
ladder, Qiagen, Hilden, Germany) and PCR samples mixed with 6x loading dye were 
applied. The electrophoresis was performed for 1 h at 100-120 V, and the gel was 
analyzed using UV light. DNA was extracted from the gel by using the QIAquick gel 
extraction kit (Qiagen, Hilden, Germany) and following the manufacturer’s protocol, or by 
centrifugation through a 0.22 µm filter (Costar® Spin-X centrifuge tube filter).  
 
50x TAE Buffer 
2 M Tris  
50 mM EDTA pH 8 
57% (w/v) acetic acid 
 
3.6.6 Restriction Digestion and Ligation 
Plasmids and PCR products were digested with the respective restriction enzymes (NEB, 
Frankfurt, Germany) following the manufacturer´s protocol. The enzymes were heat-
inactivated at 65°C for 20-30 min and the digested plasmids were purified by agarose gel 
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electrophoresis. The DNA insert was ligated with 100 ng plasmid DNA and a molar 
insert-to-plasmid ratio of 1:1, 3:1 or 5:1.  
10 µl ligation solution using 0.5 µl T4 ligase (3 U/µl, Promega, Mannheim, Germany) and 
the corresponding 5x buffer was prepared and incubated either overnight at 20°C or with 
a temperature gradient of 1°C per 1 h ranging from 25-11°C.  
 
3.6.7 Transformation of Competent Bacteria Cells 
For transformation, 100 ng plasmid DNA or 5 µl ligated plasmid solution was added to 
50 µl competent bacteria cells, and incubated for 20 min on ice. The cells were exposed 
to a heat-shock at 42°C for 30-45 s followed by incubation on ice for 2 min. After adding 
400 µl LB-media, the cells were allowed to grow for 1 h at 37°C and 750 rpm. From the 
suspension 100 µl were plated on LB-agar supplemented with the according antibiotics 
and incubated overnight at 37°C. 
 
Lysogeny Broth (LB) Media  LB-Agar Media 
1% (w/v) tryptone 
0.5% (w/v) yeast extract 
1% (w/v) NaCl 
 
 1% (w/v) tryptone 
0.5% (w/v) yeast extract 
1% (w/v) NaCl 
6% (w/v) agar 
 
 
3.7 Microbiology Methods 
3.7.1 Cultivation of E. coli 
For overnight cultures, 10-15 ml LB-media supplemented with the according antibiotics 
were either inoculated with bacteria from glycerol stocks, a single bacteria colony from 
an agar plate, or with 400 µl transformation solution. 
For test expressions 50-100 ml and for protein purification, 1-4 l LB-media supplemented 
with the according antibiotics were inoculated with overnight bacterial culture (~ 1:500). 
The bacteria were then grown at 37°C and induced at an OD600 of 0.4-0.6 with 0.2-
1.0 mM IPTG or, in case of (GCN4)3-T1L σ1, with 0.2 µg/ml anhydrotetracycline (AHTC). 
The bacteria grew overnight at 20-25°C and 110 rpm, while (GCN4)3-T1L σ1 was 
produced at 37°C and the cells were harvested 5 h after induction. During test 
expressions, samples were collected at various time points, and similar amounts of cells 
were analyzed with SDS-PAGE. 
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3.7.2 Cell Harvesting 
Cells were harvested by centrifugation at 7000 rpm (rotor: SLC-4000, Sorvall) for 10 min 
at 4°C. Cell pellets were either directly used for protein purification, or flash frozen in 
liquid nitrogen and stored at -80°C. 
 
3.8 Protein-Biochemistry 
3.8.1 Discontinuous SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
SDS-PAGE was used to separate protein mixtures according to their molecular weight in 
an electrical field and to analyze the protein purity. SDS-PAGE gels with 12 or 15% 
separation and 4% stacking gels were prepared. Samples were mixed with 4x SDS-
sample buffer and heated to 90°C for 2-5 min. The electrophoresis was performed for 1 h 
at 45 mA. Gels were stained with Coomassie staining solution for 10-15 min on an orbital 
shaker.  
 
4 x SDS gels 4% Stacking gel 12% Separation gel 15% Separation gel 
H2O (ml) 6.1 5 3.5 
1.5 M Tris pH 6.8 (ml) 2.5   
1.5 M Tris pH 8.8 (ml)  3.75 3.75 
10 % (w/v) SDS (µl) 100 150 150 
30% Acrylamide-
bisacrylamide (ml) 
1.3 6 7.5 
TEMED (µl) 10 7.5 7.5 
10% (w/v) APS (µl) 100 150 150 
 
 
4x SDS Sample Buffer  Coomassie Staining Solution 
20 ml 1 M Tris pH 6.8 
10 ml 10% SDS 
 0.25 g Coomassie Brilliant Blue G250 
100 ml ethanol 
1.63 ml 0.5 M EDTA pH 8.0  900 ml H2O 
4 ml β-mercaptoethanol 
20 mg bromophenol blue 
 2.5 ml conc. HCl 
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3.8.2 Cell Lysis 
Per 1 g cells, 4-6 ml lysis buffer was used for resuspension. The solution was 
supplemented with 1 mM PMSF and the cells were lysed by sonication. Lysis tests with 
1 ml volume were conducted with an amplitude of 30% and an overall pulse time of 0.5-
1 min (cycles of 0.5 s pulse on and 5 s off). The solution was centrifuged at 12 000 rpm 
(Eppendorf centrifuge) for 30 min at 4°C.  
Lysis of 20-30 ml cell solutions was done with an amplitude of 40% and an overall pulse 
time of 2-4 min (cycles of 0.5 s pulse on and 0.5 s off), and the lysed cells were 
centrifuged at 17 000 rpm (rotor: SS-34, Sorvall) for 1 h at 4°C. The supernatant was 
sterile filtered through a 0.22 µm filter. 
 
Protein Lysis Buffer 
His6-SUMO-T1L σ1 50 mM Tris pH 7.8 
3 mM EDTA 
T1L σ1(29-470) 40 mM Tris pH 8.5 
T1L σ1(cc-body) 50 mM Tris pH 8.0 
300 mM NaCl 
10 mM imidazole 
(GCN4)3-T1L σ1 20 mM Tris pH 7.4 
40 mM NaCl 
5 mM MgCl2 
T1L σ1(29-159) 40 mM HEPES pH 7.4 
150 mM NaCl 
T3D σ1(cc and cc-body) 50 mM Tris pH 8.0 
300 mM NaCl 
10 mM imidazole 
 
Lysis Test  Buffer Condition 
1 100 mM Tris pH 7.6, 10% glycerol 
2 100 mM Tris pH 7.6, 50 mM LiCl 
3 100 mM HEPES pH 7.0, 100 mM KCl 
4 100 mM Tris pH 8.2, 50 mM NaCl, 10% isopropanol 
5 100 mM HEPES pH 7.0, 1 M MgSO4 
6 100 mM Tris pH 8.2, 50 mM NaCl, 100 mM urea 
7 100 mM KH2PO4, 2.5 mM ZnCl2 pH 4.3 
8 100 mM KH2PO4, 50 mM (NH4)2SO4 pH 6, 1% Triton X-100   
9 100 mM HEPES pH 7.0, 100 mM sodium glutamate, 5 mM DTT 
10 100 mM Triethanolamin, 50 mM LiCl, 5 mM EDTA pH 8.5 
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11 100 mM sodium acetate, 1M MgSO4 pH 5.5 
12 100 mM sodium acetate, 100 mM KCl, 0.1% n-Octyl-β-glucoside pH 5.5 
13 50 mM HEPES pH 8.5, 1 M L-arginine 
14 50 mM HEPES pH 8.5, 0.3 M L-arginine 
15 50 mM HEPES pH 6.5, 1 M L-arginine 
16-18 50 mM MES pH 5.5-6.5, (steps of 0.5), 300 mM NaCl 
19-24 50 mM HEPES pH 7-8.5 (steps of 0.5), 300 mM NaCl 
25 50 mM Bicine pH 9, 150 mM NaCl 
 
 
3.8.3 Refolding of Inclusion Bodies 
The membrane-containing layer of the cell lysate pellet was removed, and the remaining 
pellet was resuspended in wash buffer. The solution was centrifuged at 17’500 rpm 
(rotor: SS-34, Sorvall) for 30 min and the pelleted inclusion bodies were resuspended in 
Tris buffer. This step was repeated three times. The resulting pellet was dissolved in 
denaturing buffer, and the solution was stirred overnight at ~ 25°C. Insoluble particles 
were separated by centrifugation at 15’000 rpm for 20 min (rotor: SS-34, Sorvall). The 
protein in the supernatant was refolded by dialysis against refolding buffer. After 24 h 
and two buffer changes, the protein solution was sterile filtered (0.22 µm) and 
concentrated to ~ 7 mg/ml. The protein was transferred into buffer A by using a PD-10 
desalting column (GE Healthcare) following the manufacturer’s protocol. 
 
Protein Buffer Composition 
(GCN4)3-T1L σ1 Wash buffer 50 mM Tris pH 7.8 
10% Triton X-100 
 Tris buffer 50 mM Tris pH 7.8 
50 mM NaCl 
 Denaturing buffer 20 mM Tris pH 7.8 
6 M GdmCl 
500 mM NaCl 
10% glycerol 
 Refolding buffer 20 mM MOPS pH 7.2 
400 mM NaCl 
10% glycerol 
 Buffer A 20 mM HEPES pH 7.4 
25 mM NaCl 
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3.8.4 Ni-Affinity Chromatography 
Ni-affinity chromatography was used as a first purification step for His6-tagged proteins. 
Single-use spin columns (spin trap columns, GE Healthcare) were utilized for a first 
expression screening of new constructs. From lysis tests 1-3 ml of supernatant were 
applied to the equilibrated spin columns by several centrifugation steps. After washing 
with lysis buffer, the proteins were eluted by several centrifugation steps using buffers 
with increasing imidazole concentrations (15-500 mM). 
 
Protein Buffer A Buffer B 
T1L σ1(cc-body) 
T3D σ1(cc and cc-body)   
 
50 mM Tris pH 8.6  
300 mM NaCl 
10 mM imidazole 
50 mM Tris pH 8.6  
300 mM NaCl 
500 mM imidazole 
 
For large-scale purification, one or two connected 1 ml-columns (HisTrap FF Crude, GE 
Healthcare) were equilibrated with ~ 10 column volumes of buffer A at a flow rate of 
1 ml/min. The filtered supernatant was loaded onto the column with a flow rate of 0.3-
0.5 ml/min. The column was washed with 50-100 ml buffer A.  
T3D σ1(cc and cc-body) constructs were digested on-column with thrombin after a 
washing step with 75 mM imidazole. Then, 100-150 U thrombin was dissolved in 1-2 ml 
buffer A and the solution was applied to the column using a syringe. The protein was 
incubated with thrombin at 20°C overnight, and cleaved T3D σ1 was eluted with 40 ml 
buffer A.  
Tagged proteins were eluted from the column using linear or stepwise gradients of 
buffer B. Fractions were collected and analyzed by SDS-PAGE. The column was 
regenerated with 0.5-1 M imidazole and stored in buffer A or water.  
 
3.8.5 Trypsin Digest in Solution 
To remove the His6-tag from T1L σ1(cc-body) constructs after Ni-affinity 
chromatography, the protein was mixed with a 1 mg/ml trypsin solution and incubated for 
2-4 h at 20°C. The necessary amount of trypsin was estimated based on SDS-PAGE 
bands that correspond to T1L σ1. Approximately, 10-15 µg trypsin was used for a protein 
solution obtained out of 1 l LB-media. A 10-fold amount of trypsin inhibitor was added to 
stop the digestion before size exclusion chromatography was performed. 
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3.8.6 Anion Exchange Chromatography 
Centrifuged and sterile filtered cell lysate was, if necessary diluted in buffer A to obtain a 
salt concentration < 50 mM, and applied to the equilibrated anion exchange 
chromatography column with a flow rate of 1-2 ml/min. In case of (GCN4)3-T1L σ1, the 
protein solution obtained after refolding was applied to the equilibrated column with a 
flow rate of 0.5 ml/min. 
The flow through was collected, and after washing the column with 10 column volumes 
buffer A bound protein was eluted stepwise or with a linear gradient of 20-30 column 
volumes to 50-100% buffer B. Protein-containing fractions were analyzed by SDS-PAGE.  
 
Construct Buffer A Buffer B Column 
T1L σ1(29-470) 40 mM HEPES pH 8.5 40 mM HEPES pH 8.5 
500 mM NaCl 
 
DEAE FF 16/10 
(GCN4)3-T1L σ1 20 mM HEPES pH 7.4 
25 mM NaCl 
20 mM HEPES pH 7.4 
500 mM NaCl 
 
MonoQ 5/50 
T1L σ1(29-159) 20 mM HEPES pH 7.4 20 mM HEPES pH 7.4 
500 mM NaCl 
DEAE FF 16/10 
 
 
3.8.7 Ammonium Sulfate Precipitation  
A saturated ammonium sulfate solution was supplemented with 100 mM Tris base to 
obtain a pH of 8.5. This solution was slowly added to a protein solution that was stirred 
on ice using a burette. When the protein solution started to precipitate, the addition of 
ammonium sulfate was stopped and the solution was kept on ice to complete the 
precipitation. The suspension was centrifuged for 30 min at 10’000 rpm (rotor: SS-34, 
Sorvall) to obtain the precipitated protein. With the supernatant, the procedure was 
repeated. Precipitated protein was recovered after each centrifugation step, dissolved in 
25 mM HEPES pH 8.5, and analyzed by SDS-PAGE.  
 
3.8.8 Cation Exchange Chromatography 
Sterile filtered protein solution was applied to the equilibrated cation exchange 
chromatography column with a flow rate of 1-2 ml/min. The flow through was collected 
and, after washing the column with 50 ml buffer A, bound protein was eluted with a linear 
gradient to 100% buffer B. Protein-containing fractions were analyzed by SDS-PAGE. 
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The column was washed with a 1 M NaCl solution followed by re-equilibration in buffer A. 
For long-term storage, the column was placed on water followed by 20% ethanol. 
 
Construct Buffer A Buffer B Column 
T1L σ1(29-470) 40 mM HEPES pH 8.5 40 mM HEPES pH 8.5 
500 mM NaCl 
HiLoad S Sepharose 
16/10 
 
 
3.8.9 Formation of σ1-Fab Complexes 
The T1L σ1 head (308-470) and the T3D σ1 head (294-455) were expressed and 
purified following established protocols [17,75]. Fab fragments of the σ1-specific IgG2a 
antibodies 5C6 and 9BG5 were obtained from the Vanderbilt Antibody and Protein 
Resource (Nashville, USA).  
Complexes were formed by mixing T1L σ1 with 5C6 Fabs or T3D σ1 with 9BG5 Fabs in 
a molecular ratio of 1 to 4 in each case. The mixtures were incubated at 4°C for 45 min. 
The stable complexes were separated from excess Fabs by using size-exclusion 
chromatography.  
 
3.8.10  Size Exclusion Chromatography 
Size exclusion chromatography (SEC) was used as final protein purification step. The 
chromatography column was equilibrated with SEC buffer at 1 ml/min. Dependent on the 
column dimensions, concentrated and sterile filtered (0.22 µm) protein samples of 
0.5-2 ml volume were applied to the column with a flow rate of 1 ml/min. The absorbance 
at 280 nm was detected to visualize proteins that absorb at this wavelength. Proteins of 
interest with no or few Trp, Tyr, Phe and Cys residues were detected measuring the 
peptide bond absorbance at a wavelength of 215 or 230 nm. 
Fractions were analyzed by SDS-PAGE and the ones containing the desired protein 
were pooled and concentrated. Purified protein was either kept at 4°C or flash frozen and 
stored at -80°C. 
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Protein SEC buffer Column 
T1L σ1(29-470) 40 mM HEPES pH 8.5 
100 mM NaCl 
 
Sephacryl S-300 16/60 
T1L σ1(cc-body) 40 mM Tris pH 8.6 (7.6) 
150 mM NaCl 
 
Superdex 200 16/60 
(GCN4)3-T1L σ1 40 mM HEPES pH 7.4 
100 mM NaCl 
 
Superdex 75 10/300 
T1L σ1(29-159) 40 mM HEPES pH 7.4 
150 mM NaCl 
Superdex 200 16/60 
T3D σ1(cc and cc-body) 
except 25-291 
40 mM Tris pH 8.6 
150 mM NaCl 
 
Superdex 200 16/60 
T3D σ1(25-291) 40 mM HEPES pH 7.4 
150 mM NaCl 
Superdex 200 16/60 
σ1-Fab complexes 20 mM HEPES pH 7.4 
150 mM NaCl 
Superdex 200 10/300 
* SEC buffer is sterile filtered (0.22µm) and degassed, 4°C. 
 
3.8.11  Protein Concentration Determination 
The protein concentration was determined by measuring the absorbance of the protein 
solution at 280 nm using the law of Lambert-Beer with the theoretical extinction 
coefficient of the protein at this wavelength.  
The concentration of proteins that contain few or no Trp, Tyr and Cys residues was not 
determined. Their concentration for crystallization was adjusted by performing a 
precipitation test (3.8.12).  
 
3.8.12  Precipitation Test 
To select an appropriate protein concentration for crystallization trials, a precipitation test 
with dilution series of five ammonium sulfate (1.5-3 M) as well as five PEG4000 (10-30%) 
concentrations was performed at 20°C.  
0.5-1 µl sterile filtered (0.22 µm) protein solution was pipetted onto a glass cover slide 
and an equal volume of the highest precipitant concentration was added. The drop was 
observed using a light microscope. The protein solution was further concentrated if the 
protein did not start to precipitate within ~ 3 min. When light to medium granular 
precipitate was directly observed, the lowest precipitation concentration was tested next. 
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The protein concentration was set when the protein precipitated (as light granular 
precipitate) in an appropriate amount of time (3-5 min) within the highest two to three 
precipitant concentrations but not in the lower ones.  
 
3.8.13 Insertion of Iodide Ions into the σ1 Coiled Coil Core by Refolding  
A concentrated protein solution (~50 µl) was diluted in unfolding buffer to a urea 
concentration of ~ 5 M. For refolding, the protein was transferred into Slide-A-Lyzer MINI 
Dialysis Devices (Pierce Protein Biology Products) and incubated in 500 ml refolding 
buffer. The buffer was exchanged twice and gently stirred at 4°C for 8 h. The protein was 
concentrated to the volume used in the beginning of the procedure. 
 
Construct Unfolding buffer Refolding buffer  
T1L σ1(29-159) 20 mM HEPES pH 7.5 
100 mM NaI 
6 M urea 
20 mM HEPES pH 7.5 
200 mM NaI 
 
 
3.9 Surface Plasmon Resonance (SPR) 
3.9.1 Affinity Determination 
SPR experiments were conducted using a Biacore 2000 instrument (GE Healthcare) at 
25°C. T1L σ1 (56 kDa) or T3D σ1 (53 kDa) were covalently immobilized on the surface of 
a CM5 sensor chip by amine coupling chemistry (NHS/EDC kit, GE Healthcare) with a 
density of 25 to 60 response units (RU). Deactivated flow cells served as references.  
Concentration series of the Fab fragments (47 kDa) or human JAM-A D1D2 (23 kDa, 
amino acids 27-233), which served as analytes, were prepared by twofold dilutions in 
running buffer (10 mM HEPES pH 7.4, 150 mM NaCl, 0.05% P20). For affinity studies of 
JAM-A with σ1, JAM-A was injected onto the biosensor surface for 300 s with a 
dissociation time of 500 s at a flow rate of 50 µl/min.  
For kinetic analysis of the binding of T1L σ1 to 5C6 Fabs, each Fab-concentration was 
randomly injected in duplicate or triplicate for 500 s with a dissociation time of 1300 s and 
a flow rate of 30 µl/min. For T3D σ1-binding experiments with 9BG5 Fabs, each Fab-
concentration was randomly injected in duplicate for 210 s with a dissociation time of 
450-600 s and a flow rate of 50 µl/min. To remove the Fab fragments from the σ1-coated 
surface after each cycle, 5 µl of regeneration solution (3.3 mM glycine, pH 1.7) was 
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injected. Due to the fast dissociation of JAM-A from T1L and T3D σ1, no regeneration 
step was necessary for these measurements.  
Three or four independent experiments were performed in each case. Data from six 
different 5C6 concentrations ranging from 8 to 280 nM, and data from seven different 
9BG5 concentrations ranging from 0.6 to 37.5 nM were double referenced and fitted to a 
1:1 Langmuir binding model (BIAevaluation).  
Ten different JAM-A concentrations, ranging from 0.02 to 10 µM for binding studies with 
T1L σ1, and ranging from 0.04 to 20 µM for binding studies with T3D σ1, were double-
referenced and used for affinity determination with the BIAevaluation software (GE 
Healthcare) and Origin Pro (OriginLab, Northampton, USA).  
 
3.9.2 JAM-A Binding to a σ1-mAb Complex 
To investigate binding of JAM-A to a saturated σ1-mAb complex, a Biacore 2000 system 
was used at 25°C. T3D or T1L σ1 head was covalently coupled (NHS/EDC kit, GE 
Healthcare) to a CM5 sensor chip with an immobilization level of 25 RU and 60 RU, 
respectively.  
In case of T3D σ1, 9BG5 antibodies (301 nM) were applied for 180 s at a flow rate of 
20 µl/min. To ensure saturation of the T3D σ1-surface with the antibody, 9BG5 Fabs 
(8 µM) were coinjected for 120 s. Dissociation of 335 s was followed by an additional 
injection of 9BG5 antibodies (301 nM) for 180 s to achieve surface saturation. 
Afterwards, the soluble ectodomain of JAM-A (8 µM) was coinjected for 120 s. 
Dissociation was followed by regeneration with 3.3 mM glycine, pH 1.7. Subsequently, 
the response of 9BG5 Fabs (8 µM) or JAM-A (8 µM) to the regenerated T3D σ1-surface 
was tested by injection for 120 s. 
In case of T1L σ1, first the response of 5C6 Fabs (4.4 µM) to σ1 alone was tested by an 
injection for 120 s at a flow rate of 20 µl/min. A dissociation step of 222 s was followed by 
regeneration with 3.3 mM glycine, pH 1.7. The response of the JAM-A ectodomain 
(14 µM) to σ1 alone was tested by injection for 120 s. Due to the fast off-rate no 
regeneration was required. 5C6 mAbs (4 µM) were injected for 600 s first and 
additionally for 300 s, to achieve surface saturation. Immediately afterwards 5C6 Fabs 
were injected (4.4 µM, 120 s) to determine whether all accessible binding sites of σ1 
were bound by the mAb. The JAM-A ectodomain (14 µM) was injected for 120 s. 
Dissociation was followed by regeneration with 3.3 mM glycine, pH 1.7. Subsequently, 
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the response of 5C6 Fabs (4.4 µM) or JAM-A (14 µM) to the regenerated T1L σ1-surface 
was tested by injection for 120 s. 
 
3.10 Crystallographic Methods 
3.10.1  Protein Crystallization and Cryoprotection 
Protein crystals are highly ordered three-dimensional arrays formed by non-covalent 
interactions between adjacent molecules. X-ray diffraction of a protein crystal can be 
used to determine the three-dimensional structure of the macromolecule. 
The commonly used sitting or hanging drop vapor diffusion crystallization methods aim to 
crystallize proteins from a supersaturated aqueous solution by slowly increasing 
precipitant and protein concentrations. Precipitants are usually salts, alcohols, or water-
soluble polymers such as polyethylene glycols (PEGs). 
 A drop of purified protein diluted with a crystallization condition is set on a plateau 
(sitting drop) or on a glass cover slide, which is then placed upside down (hanging drop), 
in an air-tight compartment. The compartment contains a reservoir with a larger volume 
of the crystallization condition. Ideally, the protein solution is under-saturated in the 
beginning. Due to lower concentrations of the solutes in the drop in comparison to the 
reservoir, water diffuses from the drop into the reservoir. The protein and precipitant 
concentrations increase in the drop and the solution becomes supersaturated. If the 
supersaturated solution reaches the nucleation zone, spontaneous nuclei can be formed 
and initiate crystal growth. Protein molecules from the solution can accumulate in an 
ordered manner at the nuclei and thereby the concentration of free protein decreases 
until the protein solution reaches the under-saturated zone. Then, crystals can still grow 
at the costs of other crystals. Among parameters that can influence crystallization are the 
initial protein and precipitant concentration, the pH, the presence of salts or organic 
compounds, and the temperature. 
Seeding experiments are alternative approaches to induce nucleation within the 
crystallization trial. Solid material, e.g. small or crushed crystals or crushed spherulites, 
can be used as nucleating agents. The seeds are transferred to the crystallization drop, 
bypassing the nucleation step so that a lower level of supersaturation is required for 
crystal growth.  
Depending on the size of the seeds added to the crystallization drop, the seeding 
technique is classified into macro- or mircoseeding. In macroseeding approaches, 
crystals of typically 5-50 µm in size are transferred to the pre-equilibrated protein solution 
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to continue crystal growth, while in the microseeding approach small nuclei are added to 
solutions of metastable supersaturation. 
In the X-ray diffraction experiment, protein crystals are exposed to high doses of high 
energetic electromagnetic radiation. Incoherent scattering of the X-ray photons causes 
the formation of free reactive radicals, which lead to radiation damage of the crystal. To 
reduce the decay of the crystals during data collection, the crystals are cooled to 
cryogenic temperatures (100 K) that limit the movement of the free radicals. Prior to 
flash-cooling, the crystal is transferred into the crystallization solution containing a 
cryoprotectant agent. Cryoprotection prevents the formation of crystalline ice that would 
harm the crystal structure and lead to strong diffraction of the formed ice crystals.  
Initial crystallization trials were performed in 96-well sitting drop crystallization plates 
(Intelli plate, Art Robbins Instruments, USA) with commercial screens and a reservoir 
volume of 100 µl. Drops were set containing 0.3 µl protein and 0.3 µl reservoir volume. A 
robot (freedom evo, Tecan) was used for pipetting. The plates were incubated at 4 or 
20°C.  
Crystallization hits were first optimized by hanging drop vapor diffusion experiments in 
24-well crystallization plates (VDX plate, Hampton Research). Usually, the pH was varied 
versus the precipitation concentration. A reservoir volume of 500 µl was used, and drop 
sizes ranging from 1-3 µl with equal volumes of protein and reservoir solution. The 
reservoir was overlaid with 150 µl silicon oil to slow vapor diffusion in case of fast 
growing crystals.  
To optimize crystals by microseeding, grown crystals were crushed in 50 µl mother liquor 
by vortexing for 5 min or for 90 s with a Teflon-bead (Seed-bead kit, Hampton research, 
USA). Serial tenfold dilutions were prepared with mother liquor. The microseeds were 
transferred to freshly prepared crystallization drops by either adding 0.2 µl or by dipping 
a cat-whisker first into the seed-containing solution and then striking through the new 
drop.  
Crystal optimization trials using an additive screen (Hampton research, USA) were 
performed in 96-well crystallization plates (Greiner Bio-One, Germany). A crystallization 
condition was selected that previously yielded reproducible crystals. 100 µl of that 
solution was transferred into each reservoir and mixed with 10 µl of one of the 96 
additive screen solutions with a robot (Hydra96, Robbins Scientific). Sitting drops of 
0.3 µl protein solution and 0.3 µl reservoir solution were set by a robot (freedom evo, 
Tecan). For data collection, crystals were transferred to a crystallization solution 
containing MPD as cryoprotectant, if necessary and were flash-frozen in liquid nitrogen. 
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3.10.2  Data Collection and Data Processing 
Background 
X-ray radiation is scattered by the electrons of the molecules in the protein crystal. The 
scattered waves will cancel each other out by destructive interference, unless the path 
difference between two waves is an integer multiple of the wavelength. The constructive 
interference amplifies the intensity and diffraction as discrete and measureable maxima 
can be observed on a detector at a specific distance. 
The high order of a protein crystal, an arrangement of small repeating units (unit cells) 
translated in three dimensions, is indispensable for the method as the conditions for 
constructive interference are fulfilled at corresponding positions between the unit cells, 
which leads to an amplification of the scattering signal. The unit cell that builds up the 
crystal lattice is defined by the length of the axes a, b and c, as well as by the angles α, β 
and γ between them. The unit cell can contain one or more entities that often can be 
transformed into each other by symmetry operations such as translation or rotation. 
Since proteins are chiral molecules, symmetry elements such as inversion centers or 
mirror planes that would change the chirality of the molecules are not possible in protein 
crystals. Symmetry operators that describe the internal symmetry of the unit cell and 
apply to the entire crystal are crystallographic symmetry operators that divide the unit cell 
into smaller fractions, termed asymmetric units. The content of the asymmetric unit can 
have symmetry, but this additional symmetry, termed non-crystallographic symmetry 
(NCS), only applies to the molecules inside the asymmetric unit. The geometry of the unit 
cell and the crystallographic symmetry operators define the space group of a crystal.  
The virtual lattice that can be generated from the recorded diffraction maxima is related 
to the crystal lattice by an inverse relationship and is termed reciprocal lattice. The Miller 
indices h, k and l specify lattice planes in the reciprocal lattice and their direction in the 
three-dimensional crystal. Each diffraction spot can be constructed as the reflection of 
the incident beam on a set of parallel planes with equal distance. Sir W. Lawrence Bragg 
described the conditions under which constructive interference is achieved, causing a 
reflection (h,k,l) on a detector. A reflection can only occur if the path difference of two 
waves that hit crystal lattice planes spaced with the distance d under angle θ is an 
integer multiple of the wavelength (Bragg’s law, equation 3.1). 
 
𝑛𝜆 = 2𝑑 𝑠𝑖𝑛θ           (3.1) 
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A graphical construction of reciprocal lattice points that fulfill Bragg’s law is the Ewald 
sphere (Figure 3.1). A sphere with radius 1/λ is drawn around a crystal. Only the 
reciprocal lattice points (h,k,l) that lie on the surface of the sphere can be observed as 
reflections. The lattice point (0,0,0) is the origin of the reciprocal lattice and defined as 
the position where the incident beam intersects the Ewald sphere. As only a fraction of 
reflections can be observed at a given crystal orientation, the crystal in the center of the 
sphere, and with it the reciprocal lattice, is rotated around its own origin, perpendicular to 
the X-ray beam, during data collection. Different lattice points will then intersect the 
Ewald sphere and will be recorded. To collect all reflections of a crystal, images are 
collected for every 0.1-2° of rotation. The range of degrees that needs to be recorded for 
a complete data set depends on the symmetry of the crystal. 
 
 
Figure 3.1 Bragg’s law and Ewald sphere. (A) Graphical representation of Bragg’s law. For 
constructive interference, the path difference of two waves diffracted at parallel crystal lattice planes 
must be an integer multiple of the wavelength. d: distance between two lattice planes, θ:angle of 
incidence. (B) Ewald sphere. r: radius of the sphere 1/λ, (h,k,l): coordinates of the reflection in 
reciprocal space, d*:1/d. 
 
Every diffraction spot on a detector corresponds to one set of lattice planes and can be 
assigned to the corresponding reciprocal space coordinates (h,k,l) during indexing of the 
data. The obtained information of the spot positions together with the distance of the 
detector and the used wavelength allows the calculation of possible unit cell parameters 
for each lattice type. Depending on the unit cell parameters and how well they fit the 
geometric requirements of a crystal system, the most likely lattice type is chosen. For 
indexing only a subset of the images is typically used.  
While the position of the diffraction spots on the images is dependent on the geometry of 
the crystal and the experiment, the intensity and phase are dependent on the content of 
the unit cell (on the structure of the molecules).  
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During integration, the intensity of each reflection is determined and the unit cell and data 
collection parameters are concurrently refined. The same reflection may have been 
collected at different intensity values during data collection caused by X-ray radiation 
damage or intensity fluctuations of the incident beam. Scaling attempts to make the data 
internally consistent and applies scaling factors to minimize the differences between the 
same reflections. Further, partial reflections that were not fully recorded on a single 
image are added, and symmetry-related reflections are merged.  
The output of scaling contains a list of all unique reflections (h,k,l) with their intensities, 
information about the best determined values for of the unit cell, and data collection 
parameters as well as statistics to assess data quality. 
The data processing R-factors calculate the consistency of repeated measurements and 
thereby quantify the overall quality of the intensity data. The linear merging R-factor, 
Rmerge, measures the ratio between the sum over the deviations of each redundant 
reflection from the mean intensity value for that reflection and the sum over the 
intensities of all redundant reflections (equation 3.2). Rmerge increases with higher 
redundancy, meaning that a low-redundant dataset appears better than a high-redundant 
one, which is counterintuitive as with increasing multiplicity the mean intensity of a 
reflection should be determined with higher accuracy. The redundancy-independent R-
factor Rmeas was therefore introduced and corrects the rise of the R-factor with 
redundancy (equation 3.3) [99]. The R-factors typically increase with higher resolution, 
while the signal to noise ratio, I/σI, decreases as the effect of small irregularities within a 
crystal increases.  
 
𝑅𝑚𝑒𝑟𝑔𝑒 =  
∑ ∑ |𝐼ℎ𝑘𝑙,𝑖− 𝐼ℎ𝑘𝑙,𝑖|
𝑛
𝑖ℎ𝑘𝑙
∑ ∑ 𝐼ℎ𝑘𝑙,𝑖
𝑛
𝑖ℎ𝑘𝑙
      (3.2) 
 
𝑅𝑚𝑒𝑎𝑠 =  
∑ √
𝑛
𝑛−1
∑ |𝐼ℎ𝑘𝑙,𝑖− 𝐼ℎ𝑘𝑙,𝑖|
𝑛
𝑖ℎ𝑘𝑙
∑ ∑ 𝐼ℎ𝑘𝑙,𝑖
𝑛
𝑖ℎ𝑘𝑙
      (3.3) 
 
A different data quality indicator, the correlation coefficient CC1/2, was introduced recently 
[100]. To obtain CC1/2, the data are divided into two parts, each containing a random half 
of the measurements of each unique reflection, and the Pearson correlation coefficient 
between the average intensities of each subset is determined. CC1/2 is near 1.0 at low 
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resolution and drops to 0 at high resolution. The Student's t-test can indicate where 
statistical significance ends. 
To discard weak data, the inclusion of which might degrade the quality of the resulting 
model, the quality indicators (Rmeas, CC1/2) are widely used to determine the resolution 
cut-off.  
After scaling, the space group is determined. It cannot be derived from the lattice type as 
it depends on symmetry operators within the unit cell. If reflections have been merged 
that are related by crystallographic symmetry operators the merging R-factor is low, while 
merging of reflections that are not truly symmetry related causes high R-factors, even at 
low resolution. 
Plotting the mean intensity against the resolution expressed as sin2θ/λ, yields a 
characteristic curve (Wilson plot) where the intensity decreases with higher resolution. 
Solvent effects cause a minimum at ~ 5 Å, and a maximum at ~ 4-3.5 Å is caused by the 
length of interatomic distances in proteins. At resolutions higher than 3.5 Å the intensity 
falls linearly and the slope of a linear regression of this region determines the Wilson 
B-factor [101]. It represents the decrease of intensity in diffraction due to thermal 
vibration and static crystal disorder. 
 
Experimental Procedure 
The diffraction capabilities of the crystals were tested first at an in house X-ray system 
equipped with the X-ray generator MicroMax-007HF (Rigaku) and a MAR345 dtb image 
plate detector at CuKα-radiation (λ=1.5418 Å). Data sets were collected at the PXIII 
beamline at the Swiss Light Source (Paul Scherrer Institute, Villigen, Switzerland) with a 
PILATUS (Pixel Apparatus for the SLS) detector and a wavelength of 1 Å.  
For phasing of T1L σ1(29-159) via single-wavelength anomalous diffraction (SAD), one 
360°-data set at a wavelength of 1 Å and eight 720°-data sets at a wavelength of 2 Å 
were collected from one iodide-containing crystal. The χ-angle was increased by 5° from 
one dataset to the other to obtain highly redundant and complete diffraction data. Data 
sets were indexed, integrated and scaled using XDS [102]. 
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3.10.3  Structure Determination and Refinement 
Background 
The intensity and the phase of a reflection (h,k,l) are dependent on the electron 
distribution of the unit cell content. Each scattered X-ray beam that leads to a reflection 
(h,k,l) can be described as a structure factor Fhkl containing its amplitude |Fhkl| and phase 
φhkl. The structure factor Fhkl is a complex number and can be expressed as a vector in 
the Gaussian plane (equation 3.4) with the length and angle corresponding to the 
amplitude and phase, respectively.  
 
Fhkl =  |𝐹ℎ𝑘𝑙| ∙ (cos φℎ𝑘𝑙 + i sin φℎ𝑘𝑙) =  |𝐹ℎ𝑘𝑙| exp(iφℎ𝑘𝑙)   (3.4) 
 
The amplitudes and the phases of the scattered beams are linked to the scattering 
matter of the unit cell by a Fourier transformation, with the sum over all atoms n, the 
atomic scattering factor fn of atom n and its position in the dimensions x, y and z. 
 
Fhkl =  ∑ 𝑓𝑛
𝑁
𝑛=1 ∙ exp[2πi(h𝑥𝑛 + k𝑦𝑛 + l𝑧𝑛)]     (3.5) 
 
Both phase and amplitude of each scattered wave contain information about all atoms in 
the unit cell. By determining the amplitude and phase for each Fhkl and applying the 
Fourier transformation one can calculate electron density that allows to determine the 
structure. The structure factor amplitudes can be determined from the diffraction data via 
the intensity Ihkl. The intensity of a reflection is proportional to the square of the structure 
factor amplitude. However, the phases cannot be measured directly from the diffraction 
experiment. To overcome the so called phase problem different indirect methods have 
been developed such as molecular replacement (MR), single or multiple isomorphous 
replacement (SIR/MIR), SAD or multiple-wavelength anomalous dispersion (MAD). In 
this thesis, SAD and MR were used for structure determination.  
 
Molecular Replacement 
If a structurally similar model to the protein of interest is available, molecular replacement 
can be successfully performed. To obtain phases, the search model is first rotated and 
then translated in space to place it in the (new) asymmetric unit so that it fits the target 
structure.  
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The Matthews coefficient VM gives an estimate on how many copies n of the molecule 
are contained in the asymmetric unit and should be placed [103]. Proteins have a 
relatively uniform density, and protein crystals contain usually a high solvent content of 
about ~ 20-70%. Thus, the coefficient VM is usually in the range of 1.75-4.2 Å3/Da and is 
calculated from the volume of the unit cell Vunit cell, the molecular weight of the molecule 
Mw and the number of asymmetric units in the unit cell nASU (equation 3.6). 
 
𝑉𝑀 =
𝑉𝑢𝑛𝑖𝑡 𝑐𝑒𝑙𝑙
𝑀𝑤 ∙𝑛𝐴𝑆𝑈∙𝑛
          (3.6) 
 
The rotation and translation of the search model are independently performed in 
Patterson space. The Patterson function is the Fourier transform of |Fhkl|2 and the 
calculated map is equivalent to the convolution of the electron density with itself. The 
Patterson space of N atoms contains all N(N-1) interatomic distance vectors. The vectors 
are independent from the phases of scattered X-rays, can also be calculated from an 
existing atomic model and are very similar between closely-related structures. 
The Patterson function of the experimental data as well as of the search model are 
calculated. The rotation of the search model around all three axes results in a peak 
within the rotation function if the orientation of the Patterson maps correlate. The rotation 
function considers only intramolecular distance vectors as they are independent from 
translation. 
During the translation search, only intermolecular distances (which can be distinguished 
from the intramolecular vectors by their longer length) are taken into consideration and 
the model is translated along the three axes. The translation function features a peak for 
the correct translation vector. 
Initial phases derived from the search model together with the structure factor amplitudes 
from the diffraction experiment can be used to calculate an initial electron density map 
(equation 3.7). The electron density ρ at a position in the unit cell xyz is calculated using 
the unit cell volume V and the structure factors Fhkl.  
 
ρ𝑥𝑦𝑧 =
1
𝑉
 ∑ 𝐹ℎ𝑘𝑙ℎ𝑘𝑙 ∙ exp[−2πi(h𝑥𝑛 + k𝑦𝑛 + l𝑧𝑛)]   (3.7) 
 
 38 
 
Single-wavelength Anomalous Diffraction 
A different approach to derive phases exploits the phenomenon of anomalous diffraction 
of heavy atoms that are intrinsically present in the protein or have been added. The 
atomic scattering factor fn is dependent on the electron distribution of an atom and 
contains the normal scattering term f0 (dependent on the Bragg angle) and the 
anomalous scattering factors f’ (dispersive term) and f’’ (absorption term), which are 
dependent on the wavelength (equation 3.8).  
 
f𝑛(θ, λ) = 𝑓0(𝜃) + f′(λ) + if′′(𝜆)       (3.8) 
 
X-ray absorption occurs near an absorption edge when the X-ray energy is sufficiently 
high to promote an inner electron of the atom. Most elements with a Z > 18 have an (K- 
or L-) absorption edge that lies in an X-ray energy range that most synchrotrons can 
provide, or have (at least) an absorption edge above available wavelengths to yield an 
anomalous signal. Anomalous scattering occurs with a phase shift of 90° in term f’’ 
relative to the normal scattering of the atom. This generates anomalous differences 
between the two structure factors of a Friedel pair (and for structure factors of a Bijovoet 
pair) that causes the Friedel law (|Fhkl|=|F-h-k-l|) to break (Figure 3.2). The anomalous 
differences can be obtained and used to locate the positions of the anomalous scatterer. 
 
 
Figure 3.2 Breakdown of Friedel’s law. (A) The anomalous scattering effect causes Friedel’s law to 
break down, meaning |Fhkl|≠|F-h-k-l| or |FPH(+)|≠|FPH(-)|. 
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In a SAD experiment, usually all diffraction data are collected from a single crystal 
containing an anomalous scatterer, and thus nonisomorphism is not a problem in this 
phasing strategy. The measurement is performed at one wavelength (which generates 
the maximum anomalous f’’ signal possible) and only provides the anomalous 
differences (Δano = F± = |FPH(+)| - |FPH(-)|). These differences are used to estimate the 
heavy atom contribution to the scattering, and then direct or Patterson methods are used 
to obtain the positions of the heavy atom substructure. The amplitude and phase of the 
substructure can be calculated, but α phase ambiguity remains in the phase of the 
protein structure factor, and resolving this requires the use of density modification. 
 
Structure Refinement 
Structural refinement is an iterative process in which the atom coordinates and 
temperature factors are improved to obtain a better correlation between the built model 
and the experimental data. The refinement process is monitored by calculating 
crystallographic R-factors with the observed (Fobs) and calculated (Fcalc) structure factor 
amplitudes.  
 
R =  
∑ |𝐹𝑜𝑏𝑠(hkl)− 𝐹𝑐𝑎𝑙𝑐(hkl)|ℎ𝑘𝑙
∑ 𝐹𝑜𝑏𝑠(ℎ𝑘𝑙)ℎ𝑘𝑙
      (3.9) 
 
For a perfect agreement R would be 0 and for a random structure model it is near 0.59. 
As this factor can be made arbitrary low by introducing more adjustable variables 
(overfitting), the unbiased R-factor Rfree was introduced to assess model and refinement 
quality [104]. A small subset of reflections (5-10%) is flagged as “free” and is not used 
during refinement. The larger (“working”) set of reflections is then referred to Rwork. The 
Rfree value is an unbiased estimate of the improvement of the structure model and is 
usually higher than Rwork. 
 
Experimental Procedure 
To obtain phase information via SAD, the program autoSHARP [105] was used in case 
of T1L σ1(29-159). The program Phaser [106] of the CCP4 package [107] was used for 
solving the phase problem via molecular replacement. The used search models are 
listed below:  
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Construct Search model Source  
(GCN4)3-T1L σ1(29-159) - residues 29-76 of  
  (GCN4)3-T1L σ1(29-76)-(GCN4)3 
provided by K. Reiss  
T3D σ1(25-291) - residues 170-265 of T3D σ1(170-455) 
- T1L σ1(29-159)* 
PDB ID: 3S6X  
this work 
T3D σ1(1-168) - residues 27-168 of T3D σ1(25-291) this work 
T1L σ1-5C6Fabs  - residues 308-470 of T1L σ1(265-470) PDB ID 4GU3 
 - Fab of IgG2a(κ) 9BG5 this work 
T3D σ1-9BG5Fabs  - T3D σ1(293-455) 
- IgG1(κ) Fab 
PDB ID 2OJ5 
PDB ID 1FIG 
* modified with the CCP4 program chainsaw using a T1L-T3D σ1 sequence alignment 
 
Alternating model building and refinement cycles were performed. Model building was 
done using Coot, and structural refinement was performed with the programs REFMAC5 
[108], autoBuster [109] or phenix [110]. 
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4 Results 
4.1 T1L σ1 Fragments 
 
Figure 4.1 Overview of T1L σ1 constructs. White boxes of varied length according to the number of 
amino acids and domains that are covered by the σ1 fragments. The three constructs comprising the 
σ1 tail, body, and head domain are discussed in sections 4.1.1 and 4.1.2, the three constructs 
comprising the tail and parts of the body domain are discussed in section 4.1.3, and the two constructs 
comprising only the tail domain are discussed in section 4.1.4. His6-tag is shown as red, SUMO-tag as 
green, and the (GCN4)3-motif as a blue box. Ulp1 and thrombin (Thro) cleavage sites are indicated. 
Constructs that led to a crystal structure are marked with a yellow star. Diffraction data is available for 
constructs marked with a black star, but the structure is currently not solved. 
 
4.1.1 His6-SUMO-T1L σ1(2-470 and 29-470) 
The T1L σ1 constructs comprising amino acids 2-470 and 29-470 were cloned via BsaI 
and XbaI restriction enzyme sites into the pE-SUMOpro vector. Both proteins were 
produced at 20°C and 37°C after IPTG induction, indicated by the appearance of bands 
in an SDS-PAGE gel that correspond to the molecular weights of the proteins (Figure 
4.2). Test Ni-affinity chromatography with single-use spin columns revealed that both 
proteins bind to the column and elute at the highest imidazole concentration used. 
 
 42 
 
 
Figure 4.2 Test expression and spin-trap test. (A) His6-SUMO-T1L σ1(2-470). SDS-PAGE gel of 
the test expression performed at 20 and 37°C. In comparison to the sample taken pre-induction (pre) 
with IPTG, a band appears at ~64 kDa that corresponds to the molecular weight of the target protein. 
(B) His6-SUMO-T1L σ1(2-470). SDS-PAGE gel of the test Ni-affinity chromatography. The soluble (S) 
and the pellet (P) fraction after lysis show a thick band at ~64 kDa. Elution with 15 and 100 mM 
imidazole removed some non-specifically bound proteins. The protein of interest and other proteins 
eluted with 500 mM imidazole. (C) His6-SUMO-T1L σ1(29-470). SDS-PAGE gel of the test expression 
performed at 20 and 37°C. In comparison to the sample taken pre-induction (pre) with IPTG a band 
appears at ~61 kDa that corresponds to the molecular weight of the protein. (D) His6-SUMO-T1L 
σ1(29-470). SDS-PAGE gel of the test Ni-affinity chromatography. Elution with 15 and 100 mM 
imidazole removed some non-specific bound proteins. A band at ~61 kDa is present at elution with 
500 mM imidazole. Most impurities that are present in the eluate with 500 mM imidazole are also 
present at elution with 100 mM imidazole. 
 
4.1.2 T1L σ1(29-470) 
The T1L σ1 construct, comprising amino acids 29-470, was cloned via NcoI and BamHI 
restriction enzyme sites into plasmid pET16b. The protein is untagged and, as revealed 
by lysis tests, soluble in pH 8.5 buffered solutions (Figure 4.3). Anion exchange 
chromatography was used as the first purification step. Impurities bound stronger to the 
column than did T1L σ1. Therefore, the flow through was collected, and the eluate was 
discarded. Three consecutive chromatographic separations were performed.  
Ammonium sulfate precipitation was used next to remove contaminating proteins. T1L σ1 
precipitated at a concentration of ~ 12% ammonium sulfate. The precipitated protein 
pellet was dialyzed into a buffer containing 25 mM HEPES pH 8.5. The protein of interest 
partially bound to a cation exchange chromatography column and could be eluted using 
three different conditions. The first species eluted when the buffer was changed from 
25 mM to 40 mM HEPES, the second species at a concentration of ~ 5 mM NaCl (40 mM 
HEPES), and the third species at ~ 250 mM NaCl (40 mM HEPES). SEC of protein 
samples obtained from the three different elution conditions resulted in single peaks 
corresponding to the void volume of the column.  
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Figure 4.3 Purification of T1L σ1(29-470). SDS-PAGE gels of the different purification steps are 
shown. Bands at ~ 48 kDa correspond to the molecular weight of the protein. Marker (M), soluble 
fraction after lysis (1), collected flowthrough after the third application on an AEC column (2), dissolved 
precipitated protein obtained by addition of 12%-ammonium sulfate (3), flowthrough of the cation 
exchange chromatography (4) elution through buffer change from 25 to 40 mM HEPES pH 8.5 (5,6) 
and elution with 5 mM NaCl (7) in buffer A. Protein after SEC (8). 
 
To determine if the protein was properly folded or aggregated, dynamic light scattering 
(DLS) measurements were performed (Figure 4.4). Several fractions showed a 
monodispersed peak corresponding to a mean hydrodynamic radius of 52 ± 10 nm.  
Electron micrographs that were obtained using a scanning transmission electron 
microscope (performed by York Stierhof, ZMBP Tübingen, Germany) showed that 
samples that had been diluted in PBS during sample preparation are completely 
aggregated, while samples diluted in SEC buffer were more homogenous, with fewer 
aggregates and filamentous structures.  
 
 
Figure 4.4 DLS measurement and electron micrographs of T1L σ1(29-470) after size exclusion 
chromatography. (A) DLS measurement revealed a single monodisperse peak by intensity of a mean 
size of 52 ± 10 nm. This species contributed to the overall mass and intensity to 100%. (B) Electron 
micrograph of purified T1L σ1(29-470) diluted in PBS (pH 7.4) shows an inhomogeneous sample of 
aggregated protein. The black bar corresponds to 50 nm. (C) Electron micrograph of purified T1L 
σ1(29-470) diluted in SEC buffer (pH 8.6) shows a more homogenous sample. The black bar 
corresponds to 50 nm.  
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Crystallization trials were performed, and a few crystallization hits with spherulites, tiny 
needles, or needle clusters were obtained. These crystals could not be optimized for 
structure determination. 
 
4.1.3 Coiled Coil – Body Constructs of T1L σ1 
The T1L σ1 constructs comprising amino acids 29-303, 29-265, and 29-249 were 
generated by introducing a stop codon into pET28b::His6-T1L σ1(29-470) at the 
corresponding C-terminal positions via site-directed mutagenesis.  
All three proteins were produced after induction with 0.2 mM IPTG at 20°C. The proteins 
were eluted from a Ni-affinity chromatography column with 250 mM imidazole after a 
washing step with 75 mM imidazole. Both thrombin and trypsin digestion removed the 
His6-tag from the T1L σ1 proteins. Cleavage with trypsin was preferentially used for tag-
removal in solution. On-column digestion did not result in cleaved protein.  
After buffer optimization, minor aggregation peaks on size exclusion chromatograms 
were observed for T1L σ1 (29-303) and T1L σ1 (29-249) with a SEC buffer at pH 8.6 and 
for T1L σ1 (29-265) with a SEC buffer at pH 7.6 (Figure 4.5). The concentration of the 
proteins was adjusted with a precipitation test after SEC. 
 
Figure 4.5 Purification of T1L σ1(cc-body) constructs. Size exclusion chromatogram with the 
absorbance measured at 230 nm of (A) T1L σ1(29-303), (B) T1L σ1(29-265), and (C) T1L σ1(29-249). 
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SDS-PAGE gels of the concentrated protein samples are included. Bands at ~ 30 kDa (A), ~ 26 kDa 
(B), ~ 24 kDa (C) correspond to the molecular weights of the proteins. 
Crystals were obtained for all three proteins by the vapor diffusion method (Figure 4.6). 
T1L σ1(29-303) yielded thin needles or needle clusters. Fine screening and optimization 
trials using micro seeds or the additive screen did not improve the crystal shape or the 
diffraction properties. 
 
Figure 4.6 Crystallization of T1L σ1(cc-body) constructs. Crystals of (A) T1L σ1(29-303) in 0.1 M 
sodium formate, 12% PEG3350, (B) T1L σ1(29-265) in 25% (v/v) ethylene glycol, and (C) T1L σ1(29-
249) in 20% (w/v) PEG 2000MME, 0.1 M Tris pH 8.5, 0.2 M TMNO (upper left), 2% (v/v) Tascimate pH 
8.0, 0.1 M Tris pH 8.5, 16% PEG3350 (upper right), 0.1 M HEPES pH 7.0, 30% (v/v) Jeffamine ED-
2001 (lower left), 10% isopropanol, 0.1 M MES pH 6.0, 0.2 M calcium acetate (lower right) are shown. 
 
Initial T1L σ1(29-265) crystals grew in 25% ethylene glycol at 20°C. The crystals 
dissolved in higher ethylene glycol concentrations, thus mother liquor was used as 
cryoprotectant, but led to minor ice rings on the detector. The crystals diffracted up to 
2.8 Å resolution at the PXIII beamline (SLS, Villigen, Switzerland) (Table 4.1). No 
pseudo-translation symmetry was detected by Xtriage (Phenix, [110]) or Sfcheck 
(CCP4). Molecular replacement attempts to solve the phase problem are ongoing. 
 
Table 4.1 Data collection statistics of T1L σ1(29-265) 
Data collection T1L σ1(29-265) 
Resolution range [Å] 47.9-2.8 (2.87-2.80) 
Space group R32 
Unit cell dimensions [Å] 101.0, 101.0,  456.5 
Unit cell angles [°] 90 90 120 
Completeness [%] 95.1 (96.4) 
Total reflections 94204 (6478) 
Unique reflections 21626 (1595) 
Rmeas [%] 13.6 (67.5) 
CC1/2 [%] 99.9 (91.2) 
I/σ 7.35 (1.36) 
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Wilson B [Å2] 57.6 
Values in parentheses are for the highest-resolution shell. 
T1L σ1(29-249) crystallized in several different conditions with different sizes and 
shapes. So far, one of those conditions (10% isopropanol, 0.1 M MES pH 6.0, 0.2 M 
calcium acetate) was optimized and the crystals diffracted to a resolution of about 2.0 Å 
at the PXIII beamline (SLS, Villigen, Switzerland). Due to one very long unit cell axis, 
data were collected with a detector resolution of 3-3.5 Å to ensure the separation of the 
diffraction spots. The space group could not be determined with confidence, and the data 
possess a high degree of pseudo-translation symmetry. Molecular replacement (Phaser, 
CCP4) with the structure or fragments of T1L σ1(29-159) has not lead to a reliable 
solution thus far.  
 
4.1.4 Coiled Coil Constructs of T1L σ1  
(GCN4)3-T1L σ1(29-159) – Purification and Crystallization  
The plasmid pIBA-GCN4tri::T1L σ1(29-159) was obtained from Dr. Kerstin Reiss. In this 
construct, the T1L σ1 sequence is in frame with the heptad repeat pattern of (GCN4)3. A 
stop codon is present at the end of the σ1 sequence, so that the produced protein solely 
carries the N-terminal (GCN4)3-motif, while the C-terminal (GCN4)3 and the His6-tag are 
absent.  
The protein was produced at 37°C after induction with 0.2 µg/ml AHTC for 5 h and was 
purified after refolding from inclusion bodies. The protein eluted from an anion exchange 
chromatography column with a concentration of ~ 250 mM NaCl. Size exclusion 
chromatography was used as a last purification step (Figure 4.7), and the protein was 
concentrated to 6-6.5 mg/ml for crystallization.  
Crystals of (GCN4)3-T1L σ1 were obtained with the hanging drop vapor diffusion method 
in 10% PEG8000, 0.1 M imidazole pH 8.0, 0.2 M calcium acetate at 20°C (Figure 4.7). 
Crystals were flash frozen with mother liquor containing 22% MPD as cryoprotectant, 
and X-ray diffraction data extending to 1.8 Å resolution was collected and used for 
structure determination. At this resolution, the R-factors of the structure (Rwork/Rfree: 23.9/ 
27.4%) are relatively high, a consequence of the presence of pseudo-translation 
symmetry that was estimated to be ~ 18% using Xtriage (Phenix, [110]). 
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Figure 4.7 Purification and crystallization of (GCN4)3-T1L σ1. (A) Analytical size exclusion 
chromatogram of (GCN4)3-T1L σ1. The absorbance is shown at 280 nm. The SDS-PAGE gel of the 
concentrated protein is included. A band at ~ 18 kDa corresponds to the molecular weight of a 
monomer. (B) Crystal of (GCN4)3-T1L σ1 in 10% PEG8000, 0.1 M imidazole pH 8.0, 0.2 M calcium 
acetate. 
 
(GCN4)3-T1L σ1(29-159) – Crystal Structure 
The structure was solved in the space group P21 with one σ1 trimer in the asymmetric 
unit (Table 4.2). With the exception of the first N-terminal and the last C-terminal residue 
in chain A, all amino acids of the protein are defined in the electron density. The protein 
forms an uninterrupted parallel α-helical coiled coil of ~ 230 Å in length. Within the 
crystal, the protein is tightly packed with a solvent content of only ~ 34%. Layers of 
slightly shifted coiled coils that point in one direction are surrounded by layers of coiled 
coils pointing in the opposite direction. Crystal contacts include several charge-mediated 
interactions between adjacent α-helical bundles.  
 
Table 4.2 Data collection and refinement statistics of (GCN4)3-T1L σ1 
Data collection (GCN4)3-T1L σ1 
Resolution range [Å] 43.9-1.82 (1.87-1.82) 
Space group P21 
Unit cell dimensions [Å] 65.3 35.6 89.3  
Unit cell angles [°] 90.0 108.4 90.0 
Completeness [%] 97.5 (96.3) 
Total reflections 234707 (16860) 
Unique reflections 34717 (2533) 
Rmeas [%] 8.2 (90.2) 
CC1/2 [%] 100 (84.3) 
I/σ 15.6 (2.6) 
Wilson B [Å2] 30.9 
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Refinement  
Rwork/ Rfree [%] 23.9/ 27.4 
Atoms  
     Protein 3461 
     Waters 161 
     Cl- 2 
     Imidazole 2 
B factors [Å2]  
     Chain A 28.0 
     Chain B 27.7 
     Chain C 26.8 
     Water 30.2 
     Cl- 20.8 
     Imidazole 29.0 
r.m.s.d. bond lengths [Å] 0.01 
r.m.s.d. bond angles [°] 0.98 
Values in parentheses are for the highest-resolution shell. 
 
The protein consists of 22.5 heptad repeats; 4 are formed by the (GCN4)3 and 18.5 by 
the σ1 segment. The amino acids at positions a and d of a heptad repeat form the 
hydrophobic core of the coiled coil. Nine interhelical salt bridges, mostly formed between 
amino acids at position g and e, stabilize the coiled coil structure. Seven salt bridges 
belong to the σ1 segment and are distributed over the entire length of the σ1 molecule. 
Few hydrophilic amino acids are located at typical hydrophobic positions a and d. N38 
and N94 occupy d positions and bind chloride ions inside the core (Figure 4.8). The B-
factors of the chloride ions and the surrounding amino acids are similar, indicating full 
occupancy of the ions (N38: 20-27 Å2, Cl-: 24 Å2, and N94: 17-19 Å2, Cl-: 17 Å2).   
A stutter is located close to the C-terminal end of the protein. This formal insertion of four 
amino acids (here: VTTE; 147-150) into the heptad repeat leads to a local unwinding of 
the α-helices and the coiled coil. The residue E150 at the d position is shifted outside of 
the core and forms a da-layer with V151. The Cβ and Cγ atoms of E150 contribute to the 
hydrophobic interaction with V151, while the carboxyl group forms a charge-mediated 
interaction with R153, which also forms a salt bridge with D155 from an adjacent subunit. 
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Figure 4.8 Crystal structure of (GCN4)3-T1L σ1(29-159). (A) The protein forms a trimeric parallel α-
helical coiled coil that has two chloride ions bound within the core. The part of the structure belonging 
to (GCN4)3 is colored grey, and the part belonging to σ1 is colored in blue, red, and yellow. Chloride 
ions are colored green (B, C) Close-up views of the bound chloride ions complexed by N38 and N94, 
respectively. View along the threefold axis of the molecule. (D) Close-up of the stutter, viewed along 
the threefold axis. E150 is shifted outward of the core and forms a da-layer with V151. (E) E150 also 
interacts with R153 that additionally forms an interhelical saltbridge with D155. 
 
T1L σ1(29-159) – Purification and Crystallization  
To verify that the σ1 tail domain independently forms a stable, trimeric coiled coil, a 
construct without the trimerization motif (GCN4)3 was designed and cloned into pET16b 
using the NcoI and BamHI restriction sites. The protein contains residues 29-159 and 
two additional amino acids (Met and Ala) at the N-terminus due to the cloning procedure.  
The protein was produced after induction with 0.3 mM IPTG at 25°C overnight and 
purified via anion exchange chromatography followed by size exclusion chromatography 
(Figure 4.9). The protein elutes early, at a retention volume that corresponds to a 
globular protein of ~ 100 kDa. This finding indicates that the protein exhibits a trimeric, 
elongated structure similar to (GCN4)3-T1L σ1(29-159). Circular dichroism (CD) spectra 
of the purified protein show that the molecule is folded and α-helical at a broad range of 
pH values (pH 1-9). Temperature-dependent CD-measurements from 10 to 95°C 
revealed a melting curve with a sharp transition from folded to random coil at 70°C 
(Rebecca Ebenhoch, Bachelor Thesis, 2014).   
For crystallization, a PEG-precipitation test was performed to adjust the protein 
concentration. Well diffracting crystals were obtained in 20% PEG8000, 0.1 M CAPS 
pH 10.5, 0.2 M NaCl at 4°C (Figure 4.9). Molecular replacement attempts with the 
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complete or partial σ1 segment of the (GCN4)3-T1L σ1(29-159) structure as a search 
model were not successful.  
Experimental phases were obtained using single-wavelength anomalous diffraction 
(SAD; Table 4.3). For this purpose, the protein was denatured and refolded in an iodide-
containing buffer to exchange the bound chloride ions of the coiled coil core. The 
refolded protein was analyzed by circular dichroism. The CD-spectra was similar to an 
untreated protein sample. Crystals were obtained in 18% PEG8000, 0.1 M CAPS pH 9.5, 
0.2 mM NaI by seeding with crystals from the original crystallization condition at 4°C. 
 
 
 
Figure 4.9 Purification and crystallization of T1L σ1(29-159). (A) Analytical size exclusion 
chromatogram of T1L σ1(29-159). The absorbance is shown at 215 nm. An SDS-PAGE gel showing 
the concentrated protein is included. A band at ~14 kDa corresponds to the molecular weight of a 
monomer. (B) Crystals of T1L σ1(29-159) in 20% PEG8000, 0.1 M CAPS pH 10.5, 0.2 M NaCl. (C) 
Crystals of refolded T1L σ1(29-159) grown in 18% PEG8000, 0.1 M CAPS pH 9.5, 0.2 M NaI. 
 
T1L σ1(29-159) – Crystal Structure 
The crystals belong to space group P21 and contain one trimeric σ1 molecule in the 
asymmetric unit. All residues except of the last C-terminal amino acid of σ1 are defined 
in the electron density.  
The protein folds into a parallel, trimeric α-helical coiled coil of ~ 190 Å in length. Similar 
to (GCN4)3-T1L σ1(29-158), the σ1 structure is stabilized by seven interhelical salt 
bridges. It is composed of 18.5 heptads and two halogenide ions that are bound by 
asparagine residues 38 and 94 inside the core of the molecule. However, the main chain 
atoms of the identical parts of the two structures superimpose with a high r.m.s.d. value 
of 2.5 Å (Figure 4.10, see Table 5.1 at page 73). Alignments of main chain atoms 
between individual chains have r.m.s.d. values of 1.54-1.82 Å.  
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Table 4.3 Data collection and refinement statistics of T1L σ1(29-159) 
Data collection  Native Refolded Refolded 
Wavelength [Å] 0.91841 1.0000 2.0000 
Resolution range [Å] 41.7-1.43 
(1.52-1.43) 
48.7-1.35 
(1.39-1.35) 
48.7-2.4 
(2.46-2.40) 
Space group P21 P21 P21 
Unit cell dimensions [Å] 53.4, 37.2, 94.9 52.7, 37.6, 89.7 52.7, 37.6, 89.7 
Unit cell angles [°] 90.0, 102.6, 90.0 90.0, 100.5, 90.0 90.0, 100.5, 90.0 
Completeness [%] 99.3 (96.1) 100 (100) 100 (100) 
Total reflections 445146 (63117) 503646 (33260) 1039304 (18914) 
Unique reflections 67304 (10401) 76273 (5563) 25687 (1566) 
Redundancy 6.6 (6.1) 6.6 (6.0) 40.5 (12.1) 
Rmeas [%] 12.3 (71.4) 10.9 (87.6) 7 (14.4) 
CC1/2 [%] 100 (96) 100 (72) 100 (99) 
I/σ 11.0 (2.1) 12.0 (1.9) 50.1 (12.9) 
Wilson B [Å2] 19.2 16.2 13.5 
Anomalous Signal [%]   4.5 (1.4) 
Refinement    
Rwork/ Rfree [%] 19.3/ 23.0   
Atoms    
     Protein 3032   
     Waters 688   
     Chloride 2   
B factors [Å2]    
     Chain A 19.0   
     Chain B 19.9   
     Chain C 18.1   
     Water 33.0   
     Chloride 15.0   
r.m.s.d. bond lengths [Å] 0.01   
r.m.s.d. bond angles [°] 0.89   
Values in parentheses are for the highest-resolution shell. 
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Figure 4.10 Superposition of the T1L σ1(29-159) and (GCN4)3-T1L σ1(29-159) structure. (A) The 
identical parts (residues 29-158 of σ1) of two structures are aligned via their coiled coil axis generated 
by the program twister [111]. The GCN4-segment is colored in grey, and σ1 is colored in blue, red, 
and yellow. Coiled coil axes are shown in grey, and α-helical axes are shown in the color of the 
according σ1 chains. The two coiled coil molecules differ in their twist. (B,C) Close up view along the 
coiled coil axis. While the three chains of the helical-bundles are properly aligned on the C-terminal 
part (C), the chains disperse at the N-terminal part of the molecules (B).  
 
The local coiled coil geometry of the two structures was analyzed with the program 
twister [111] (Figure 4.11). The stutter of T1L σ1 (VTTE; 147-150) located close to the C-
terminal end of the solved σ1 tail domain was identified and found to be compensated by 
a local unwinding of the coiled coil and the α-helices. The unwinding of the coiled coil is 
detected by a local increase of the coiled coil pitch (the distance of one full turn of the 
superhelix) that is accompanied by a local increase of the coiled coil phase yield per 
residue. A minor decrease in the α-helical phase yield per residue indicates the local 
unwinding of the α-helices.  
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Figure 4.11 Local coiled coil parameters plotted against residue numbers of (GCN4)3-T1L 
σ1(29-159) and T1L σ1(29-159). (GCN4)3-T1L σ1(29-159) plots are shown in black, and T1L σ1(29-
159) plots are shown in blue. The stutter location is indicated with a red bar. (A) Coiled coil pitch. The 
average pitch of (GCN4)3-T1Lσ1 is 157 ± 44 Å and of T1L σ1(29-159) is 174 ± 55 Å. The pitch locally 
increases at the stutter position. (B) Coiled-coil phase yield per residue (the angle between two 
consecutive residues relative to the vectors connecting the Cα-atoms and the coiled coil axis). Typical 
values for left-handed coiled coils are around -4°. Right-handed coiled coils have positive values. At 
the stutter, the coiled-coiled phase yield increases. (C) Crick α-helical phase. The Crick angle, which 
defines the phase of the Cα-atoms relative to the coiled coil axis is plotted for positions a and d. (In an 
idealized coiled coil residues in a positions have values ~ -30° and d positions have values ~ 20°). At 
the stutter the Crick angles have a minimum. Values are increased C-terminal the stutter. (D) α-helical 
phase yield per residue (the angle between two consecutive residues relative to the vectors 
connecting the Cα-positions to the α-helical axis) decreases at the stutter position.  
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4.2 T3D σ1 Fragments 
 
Figure 4.12 Overview of T3D σ1 constructs. The sizes of the σ1 fragments are indicated as white 
boxes of different length. His6-tags and the thrombin (Thro) cleavage sites are indicated. Constructs 
that led to a crystal structure are marked with a star.  
 
4.2.1 T3D σ1(28-455 and 30-455) 
The T3D σ1 constructs comprising amino acids 28-455 and 30-455 were cloned via NheI 
and BamHI restriction sites into pET28b. The His6-tagged proteins were over-expressed 
as verified by immunoblotting, but they were insoluble in all buffers tested.  
 
4.2.2 Coiled Coil – Body Constructs of T3D σ1  
The T3D σ1 constructs comprising amino acids 1-291, 1-234, 25-291, and 25-251 were 
cloned via NheI and HindIII restriction sites into pET28b. With the exception of T3D 
σ1(1-234), all constructs could be over-expressed by induction with 0.3 mM IPTG at 
20°C. The His6-tag could be removed by on-column digestion with thrombin, or the 
tagged-proteins could be eluted from the Ni-affinity chromatography column with an 
imidazole concentration of about 150 mM.  
 
T3D σ1 (25-291) – Purification and Crystallization 
His6-tagged T3D σ1(25-291) was separated from aggregated protein by size exclusion 
chromatography (Figure 4.13). The protein concentration was adjusted for crystallization 
with a precipitation test. 
Small needle clusters were obtained in 40% MPD, 0.1 M Tris pH 8.0 at 4°C. The additive 
screen (Hampton research) was applied to optimize the crystallization condition, and 
small needle-like clusters were obtained first in several conditions. After four weeks, 
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three-dimensional crystals grew in some conditions that contained linker molecules 
(10 mM taurine; 10 mM betaine hydrochloride; 3% (w/v) 1,6-diaminohexane). SDS-
PAGE with samples of dissolved crystals and the protein solution stored at 4°C revealed 
that the protein was degraded over time. The gel bands were analyzed by MALDI-mass 
spectrometry (Lisa Kraft, AK Kalbacher, University of Tuebingen). The identified 
fragments cover the T3D σ1 sequence from residue 38 almost completely until residue 
R262 (Appendix).  
 
 
Figure 4.13. Purification and crystallization of T3D σ1(25-291). (A) Size exclusion chromatogram 
of T3D σ1(25-291). The absorbance is shown at 230 nm. The protein is present in the void volume (1) 
and in the second peak (2) indicated by the SDS-PAGE gel. (B) The protein degraded over time. The 
protein solution that was used for crystallization and stored at 4°C was loaded on the SDS-PAGE gel 
~1 week after purification (4°C). Crystals that have been used for structure determination were 
dissolved and subjected to SDS-PAGE (xtal). In comparison to the freshly purified protein the majority 
of the protein runs at a lower molecular weight. (C) Initial crystals of T3D σ1(25-291) in 40% MPD, 
0.1 M Tris pH 8.0 are shown on the upper picture. Crystal used for structure determination is shown on 
the lower picture (40% MPD, 0.1 M Tris and 3% (w/v) 1,6-Diaminohexane). 
 
 
T3D σ1 (25-291) – Crystal Structure 
A complete data set to 2.25 Å resolution was collected and used for solving the structure 
by molecular replacement. The crystals belonged to space group C2 and contained one 
σ1 trimer in the asymmetric unit. 
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Table 4.4 Data collection and refinement statistics of T3D σ1(25-291) 
Data collection T3D σ1(25-291) 
Resolution range [Å] 49.1-2.25 (2.31-2.25) 
Space group C121 
Unit cell dimensions [Å] 351.2, 41.6, 63.4 
Unit cell angles [°] 90.0, 95.3, 90.0 
Completeness [%] 99 (98) 
Total reflections 295462 (22021) 
Unique reflections 43612 (3206) 
Rmeas [%] 13.3 (91.2) 
CC1/2 [%] 100 (83) 
I/σ 12.1 (2.1) 
Wilson B [Å2] 38.5 
Refinement  
Rwork/ Rfree [%] 22.3/ 24.7 
Atoms  
     Protein 4748 
     Waters 420 
B factors [Å2]  
     Chain A 46.1 
     Chain B 47.5 
     Chain C 46.5 
     Water 41.0 
r.m.s.d. bond lengths [Å] 0.004 
r.m.s.d. bond angles [°] 0.755 
Values in parentheses are for the highest-resolution shell. 
 
The protein folds into a parallel α-helical coiled coil and four triple β-spiral repeats, β1-β4 
(Figure 4.14). Few residues that belong to the short coiled coil of the T3D σ1 body 
domain are visible in the electron density (defined residues: chain A 27-243, chain B 27-
240, chain C 27-239). The body domain and the N-terminal half of the coiled coil 
contribute most of the crystal contacts. The middle part of the coiled coil does not interact 
with adjacent proteins and therefore, has temperature factors between 70-85 Å2. The 
main chain atoms of the different chains of the coiled coil superimpose with the 
appropriate T1L σ1 coiled coil residues with a r.m.s.d. value between 1.4-1.7 Å. The 
coiled coil domain consists of 20 heptads and is ~ 205 Å long. Six interhelical salt 
bridges are distributed over the entire length of the coiled coil and stabilize the structure.  
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Figure 4.14 Crystal structure of T3D σ1(25-291). The σ1 protein is colored in blue, red, and yellow. 
(A) The protein folds into a trimeric parallel α-helical coiled coil domain (residues 27-168) and a body 
domain that consists of four triple β-spiral repeats, β1-β4 (residues 169-234). (B) Close-up of the 
stutter, with view along the threefold axis. I154 is shifted outward of the core and forms a da-layer with 
Q155. (C) Q155 also interacts with R150 that also contacts T152 of an adjacent α-helix. (D) 
Backbone-backbone interactions between V170 residues at the domain-transition site. View along the 
threefold axis. (E) The two domains are connected by a direct interaction between body domain 
residue N182 and carbonyl groups of A169 and E166, which are located at the end of the coiled coil. 
An interhelical salt bridge formed by E166 and R161 stabilizes the end of the coiled coil.  
 
Few hydrophilic amino acids occupy typically hydrophobic positions a and d. Residues 
S39 (position a) and H42 (position d) bind several water molecules inside the core 
(Figure 4.15). The B-factors of the water molecules are similar to the surrounding amino 
acids, indicating full occupancy. A second histidine residue, H123, is located at position 
a, but the water bound at the trimer interface has a higher B-factor, and its electron 
density is weaker in comparison to the other bound water molecules.  
A stutter is located close to the C-terminal end of the coiled coil domain. This 
discontinuity of the heptad repeat of a four amino acid insertion (here: VTSI; 151-154) is 
compensated by a local unwinding of the α-helices and the coiled coil. The unwinding of 
the coiled coil is detected by a local increase of the coiled coil pitch and a minor 
decrease in the α-helical phase yield per residue indicates the local unwinding of the α-
helices. Residue I154 at the d position of the stutter is shifted outside of the core and 
forms a da-layer with Gln155. The Cβ and Cγ atoms of Q155 contribute to the 
hydrophobic interaction with I154. Q155 additionally interacts with R150, which further 
contacts T152 from an adjacent subunit. 
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Figure 4.15 Bound water molecules inside the core and local coiled coil parameters plotted 
against residue numbers of T3D σ1(25-291). The σ1 chains are colored in blue, red and yellow. 
Water molecules are shown as red spheres. (A) S39 at position a and H42 at position d of the heptad 
repeat bind water molecules inside the core. (B) H123 binds a water molecule at the trimer interface. 
(C) The coiled coil pitch (black line) and the α-helical phase yield (the contribution to the α-helical turn) 
per residue (blue line) are plotted against the residue number. The stutter location is indicated with a 
red bar. The average pitch of the T3D σ1 coiled coil domain was calculated with the program twister to 
148 ± 23 Å. The pitch locally increases and the α-helical phase yield per residue locally decreases at 
the stutter position. 
 
The body domain is directly connected to the coiled coil, and no intrinsic flexible region 
was observed between the two domains. N182 of the body domain interacts with 
carbonyl groups of A169 and E166, which are located at the C-terminal end of the coiled 
coil. E166 also forms an interhelical salt bridge with R161 stabilizing the end of the 
helical bundle. The β-spiral repeats, β1-β4, are similar to a previously solved T3D σ1 
structure ([19], PDB ID: 3S6X). The main chain atoms of the corresponding parts 
superimpose with a r.m.s.d. value of 0.63 Å.  
 
T3D σ1 (1-291) – Purification and Crystallization 
The cleaved protein T3D σ1(1-291) was tested for pH-stability. Size exclusion 
chromatography of the protein in different buffers demonstrated that it is almost insoluble 
at a pH of 7.6, while it is soluble at higher pH values. Minor aggregation was observed at 
a pH of 8.6 and, even after several weeks, the protein was not degraded.   
 
4.2.3 Coiled coil Construct 
T3D σ1 (1-168) – Purification and Crystallization 
The T3D σ1 construct comprising amino acids 1-168 was generated by introducing a 
stop codon into pET28b::His6-T3D σ1(1-291) at the position corresponding to Ala169 via 
site-directed mutagenesis.  
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The protein was separated from most impurities by binding to a Ni-affinity 
chromatography column. On-column digestion was followed by size exclusion 
chromatography (Figure 4.16). The untagged protein contains six additional amino acids 
(Gly-Ser-His-Met-Ala-Ser) at the N-terminus due to the cloning procedure.  
Crystals of T3D σ1(1-168) were obtained with the hanging drop vapor diffusion method in 
70% MPD, 0.1 M HEPES pH 7.5 at 20°C. A complete data set extending to 1.6 Å 
resolution was collected, and the structure was solved via determining phases by 
molecular replacement. The program Sfcheck (CCP4) [112] calculated ~25% pseudo-
translational symmetry.  
 
 
Figure 4.16 Purification and crystallization of T3D σ1(1-168). (A) Size exclusion chromatogram of 
T3D σ1(1-168). The absorbance is shown at 230 nm. An SDS-PAGE gel showing the concentrated 
protein is included. A band at ~19 kDa corresponds to the molecular weight of the protein. (B) Crystals 
of T3D σ1(1-168) in 70% MPD, 0.1 M HEPES pH 7.5 at 20°C.  
 
T3D σ1 (1-168) – Crystal Structure 
The structure was solved in the space group R32 with one σ1 monomer in the 
asymmetric unit (Table 4.5). The biological σ1-trimer is formed by the crystallographic 
symmetry. There is no electron density present for the N-terminus (residues 1-24) and 
the last six residues of the C-terminus. Residues 25-94 are well defined and possess low 
B-factors (Figure 4.17). This part of the structure is involved in most crystal contacts, 
while residues 95-162 contribute little to the crystal packing contacts, have higher B-
factors and the electron density is poorly defined. Due to the high percentage of pseudo-
translation and the region of poor electron density, the R-factors of the structure (Rwork 
23.6%, Rfree: 25.4%) are high for a resolution of 1.6 Å.  
 60 
 
 
Figure 4.17 Crystal structure of T3D σ1(1-168). (A) The σ1 monomer that forms the asymmetric unit 
is colored according to B-factors from blue (15 Å2) to red (120 Å2). The symmetry-related molecules 
that complete the σ1 trimer are colored in grey. The N-and C-termini are indicated. (B) Close-up view 
of the N-terminal residues that are defined in the electron density. (C) Well defined electron density of 
residues with low B-factors. (D) Poorly defined electron density of the C-terminal residues that have 
high B-factors. The 2Fo-Fc electron density map is contoured in blue at 1.0 σ and the Fo-Fc map is 
contoured in green at 3.0 σ and red at -3.0 σ. 
 
Table 4.5 Data collection and Refinement statistics of T3D σ1(1-168) 
Data collection T3D σ1(1-168) 
Resolution range [Å] 41.0-1.6 (1.64-1.60) 
Space group R32  
Unit cell dimensions [Å] 38.5, 38.5, 737.3 
Unit cell angles [°] 90, 90, 120 
Completeness [%] 100 (100) 
Total reflections 545257 (37568) 
Unique reflections 29360 (2077) 
Rmeas [%] 7.7 (135) 
CC1/2 [%] 100 (78.7) 
I/σ 22.9 (2.3) 
Wilson B [Å2] 31.1 
Refinement  
Rwork/ Rfree [%] 23.0/ 25.1 
Atoms  
     Protein 1003 
     Waters/ MPD 69/ 24 
B factors [Å2]  
     Chain A 56.6 
     Water 45.2  
     MPD 55.9 
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r.m.s.d. bond lengths [Å] 0.015 
r.m.s.d. bond angles [°] 1.209 
Values in parentheses are for the highest-resolution shell. 
 
4.3 Interactions between σ1 and Neutralizing Antibodies 
Figures and text are adapted with permission: Copyright © American Society for 
Microbiology, JVI, 91 2017, doi:10.1128/JVI.01621-16. 
4.3.1 Formation and Crystallization of σ1-Fab Complexes 
Stable σ1-Fab complexes were formed and subsequently purified and separated from 
excess Fabs by SEC (Figure 4.18). Crystals of the T1L σ1-5C6 Fab complex were 
obtained with a concentration of 1-4 mg/ml in 9.5-11.5% (w/v) PEG8000, 0.1 M MES (pH 
5.5-6.5), and 0.2 M zinc acetate at 4°C using the hanging-drop vapor diffusion method. 
Mother liquor containing 12% MPD was used as cryoprotectant. Diffraction data from two 
crystals were collected, processed, and merged for structure determination by molecular 
replacement. 
 
 
Figure 4.18 Complex formation and purification of σ1-Fab complexes. Size exclusion 
chromatogram with the absorbance shown at 280 nm. (A) The two peaks contain T1L σ1-5C6 Fab 
complex (peak 1) and excess of Fabs (peak 2). A SDS-PAGE gel is included. Light and heavy chains 
of 5C6 have molecular weigths of ~24 kDa, and T1L σ1 head has a molecular weight of ~18.5 kDa. 
(B) The T3D σ1-9BG5 Fab complex (peak 1) is separated from excess Fabs (peak 2). A SDS-PAGE 
gel is included. Light and heavy chains of 9BG5 have molecular weigths of ~24 kDa, and T3D σ1 head 
has a molecular weight of ~17.7 kDa. 
 
Crystals of the T3D σ1-9BG5 Fab complex were obtained with a concentration of 1-
2 mg/ml in 10-12% (w/v) PEG8000, 0.1 M Tris (pH 6.5-7.5), and 0.2 M magnesium 
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chloride at 4°C using the hanging-drop vapor diffusion method. The reservoir solution 
was covered with ~150 µl silicone oil to reduce vapor diffusion due to initially fast growing 
crystals. Mother liquor containing 12% MPD was used as cryoprotectant. The structure 
was solved by molecular replacement.  
 
4.3.2 Crystal Structure of T1L σ1-5C6 Fabs 
The 3.7 Å resolution structure of T1L σ1 head in complex with 5C6 Fabs was solved in 
space group C2 with one trimeric σ1 head and three Fab molecules in the asymmetric 
unit (Table 4.6). The variable domains (VL and VH) of 5C6 are well ordered, and the 
interaction area with σ1 is well defined in the electron density map, while the constant 
domains (CL and CH) of 5C6 are poorly visible. The T1L σ1 fragment folds into one β-
spiral repeat and the globular head domain. The upper part of the σ1 head is faced by 
the variable domains VL and VH of three Fab molecules (Figure 4.19). Each Fab spans 
two σ1 subunits. The σ1-Fab contact buries a surface of 727 Å2 from the solvent with 
light and heavy chain contributions of 171 Å2 and 556 Å2, respectively.  
 
 
Figure 4.19 Crystal structure of T1L σ1 head in complex with 5C6 Fabs. Subunits of σ1 are 
colored in blue, red, and yellow. The light and heavy chains of the 5C6 Fab fragment are shown in 
light and dark brown. (A) Top view along the σ1-threefold-axis. The σ1 head domain is surrounded by 
three Fab molecules. Each Fab fragment spans two σ1 subunits, appearing to stabilize the trimeric 
state of σ1. (B) Side view, showing 5C6 Fabs binding at the upper, C-terminal region of the σ1 head.  
 
The σ1 protein is exclusively engaged by the complementarity-determining regions 
(CDRs) of 5C6, which are referred to as L1-L3 for CDRs 1-3 of VL and H1-H3 for CDRs 
1-3 of VH, respectively (Figure 4.20). Three of the six CDRs are involved in binding σ1: 
L1, H2, and H3. L2 likely forms only a single hydrogen bond with σ1, whereas L3 and H1 
do not interact with σ1 at all. 
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Figure 4.20 Contacts between T1L σ1 head and 5C6 Fabs. Subunits of σ1 are colored in blue, red, 
and yellow. The light and heavy chains of the 5C6 Fab fragment are shown in light and dark brown. 
(A) Close-up view of 5C6 Fab binding across two σ1 subunits. CDR loops are highlighted in light (L1, 
H1), medium (L2, H2), and dark (L3, H3) green in case of VL, and grey in case of VH. Black box 
indicates the location of the interactions shown in (B). CDR H3 interacts mainly with one σ1 subunit by 
forming several hydrogen bonds with σ1 residues from four different β-strands. R424σ1 is engaged by 
the carbonyl groups of I101H3 and G103H3 and is sandwiched by Y107H3 and Y457σ1. Both Y102H3 and 
Y104H3 interact with σ1 residues from both subunits simultaneously. Y102H3 forms hydrogen bonds 
with Q371σ1, G448σ1, and Q417σ1, and Y104H3 forms hydrogen bonds with G448σ1 and D426σ1. 
 
H3 contributes substantially to the interaction with σ1. This CDR extensively contacts 
one σ1 subunit, forming multiple hydrogen bonds with σ1 residues from four β-strands. A 
key interaction involves R424σ1, which forms hydrogen bonds with the carbonyl groups of 
I101H3 and G103H3 as well as the side chain of Q417σ1. Residue R424σ1 additionally 
makes cation-π interactions with Y107H3 and Y457σ1. The long H3 CDR also contacts the 
interface of two σ1 subunits. Y102H3 and Y104H3 interact with σ1 residues from both 
subunits simultaneously. Y102H3 forms hydrogen bonds with Q371σ1, G448σ1, and 
Q417σ1 using its amine, hydroxyl, and carbonyl groups, respectively. G448σ1 and D426σ1 
are contacted by the Y104H3 side chain.  
 
Table 4.6 Data collection and refinement statistics of T1L σ1 – 5C6 Fabs 
Data collection T1L σ1 – 5C6 Fabs 
Resolution range [Å] 48.99 - 3.70 (3.80 - 3.70) 
Space group C2  
Unit cell dimensions [Å] 223.6, 129.1, 87.9 
Unit cell angles [°] 90, 101.24, 90 
Completeness [%] 99.9 (99.7) 
Total reflections 314028 (24377) 
Unique reflections 26264 (1965) 
Rmeas [%] 29.5 (161.9) 
CC1/2 [%] 99.1 (74.8) 
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I/σ 7.94 (1.71) 
Wilson B [Å2] 90.7 
Refinement  
Rwork/ Rfree [%] 23.6/ 28.0 
Atoms  
     Protein 12621 
B factors [Å2]  
     Chain A, B, C 53.2, 51.8, 54.7 
     Chain D, E,F, 119.7, 121.5, 136.9 
     Chain G, H, I 136.3, 144.7, 136.3 
r.m.s.d. bond lengths [Å] 0.01 
r.m.s.d. bond angles [°] 1.28 
Values in parentheses are for the highest-resolution shell. 
 
4.3.3 Crystal Structure of T3D σ1-9BG5 Fabs 
The 3.0 Å resolution structure of the T3D σ1 head in complex with 9BG5 Fabs was 
solved in space group P1 with two trimeric σ1 proteins and six Fab molecules in the 
asymmetric unit (Table 4.7). 
Similar to the T1L σ1-5C6 structure, three 9BG5 Fab molecules engage the head domain 
of T3D σ1, and each Fab spans two σ1 subunits (Figure 4.21). However, the location of 
the 9BG5 mAb epitope is different. 9BG5 binds to the side of the T3D σ1 head domain, 
while 5C6 engages T1L σ1 closer to the top of the head domain. The σ1-Fab contact 
buries a surface of 905 Å2 from solvent with almost equal contributions of the light 
(436 Å2) and heavy chains (469 Å2).  
 
 
Figure 4.21 Crystal structure of T3D σ1 head in complex with 9BG5 Fabs. Subunits of σ1 are 
colored in blue, red, and yellow. The light and heavy chains of the 9BG5 Fab fragment are shown in 
light and dark violet. (A) Top view along the σ1-threefold-axis. The σ1 head domain is surrounded by 
three Fab molecules. Each Fab fragment spans two σ1 subunits, appearing to stabilize the trimeric 
state of σ1. (B) Side view, showing 9BG5 Fabs binding σ1 in the middle of the head domain. 
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Five of the six CDRs are in contact with the flat epitope (Figure 4.22). L1 forms an 
extended hydrogen bond network with σ1 involving eight direct interactions. Residue 
E419σ1, which forms an intramolecular salt bridge with R427σ1, is faced by L1 residues 
S30L1, S31L1, and N32L1. Residue N32L1 also interacts with the carbonyl group of V392σ1 
and with the guanidine group of R51L2, which also forms a salt bridge with D340σ1 
located at the interface between two σ1 subunits. CDRs H1, H2, and H3 participate in 
intermolecular contacts with several hydrophobic interactions, a small number of 
hydrogen bonds, and one cation-π interaction. 
 
 
Figure 4.22 Contacts between the T3D σ1 head and 9BG5. Subunits of σ1 are colored in blue and 
yellow. The light and heavy chains of the 9BG5 Fab fragment are shown in light and dark violet. (A) 
CDR loops are highlighted in light (L1, H1), medium (L2, H2), and dark (L3, H3) green in case of VL 
and grey in case of VH. The black box indicates the location of the interactions shown in (B). The CDR 
L1 loop forms an extensive hydrogen-network with one σ1 subunit. E419σ1 makes an intramolecular 
salt bridge with R427σ1 and is faced by the three Fab residues, S30L1, S31L1, and N32L1. CDR L2 
residue R51L2 forms an intermolecular salt bridge with D340σ1 and is stabilized by a cation-π 
interaction with Y105H3. 
 
Table 4.7 Data collection and refinement statistics of T3D σ1 – 9BG5 Fabs 
Data collection T3D σ1 – 9BG5 Fabs 
Resolution range [Å] 49.04 - 3.00 (3.08 – 3.00) 
Space group P1  
Unit cell dimensions [Å] 103.2, 109.3, 131.7 
Unit cell angles [°] 103.1, 113.6, 103.5 
Completeness [%] 98.5 (98.4) 
Total reflections 338722 (26084) 
Unique reflections 94667 (7020) 
Rmeas [%] 11.6 (85.4) 
CC1/2 [%] 99.5 (64.7) 
I/σ 13.08 (1.89) 
Wilson B [Å2] 55.9 
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Refinement  
Rwork/ Rfree [%] 22.3/ 24.7 
Atoms  
     Protein 24507 
B factors [Å2]  
     Chains A, B, C 45.4, 45.9, 45.6 
     Chains D, E,F, 50.5, 52.4, 55.7 
     Chains G, H, I 75.3, 77.4, 76.3 
     Chains J, K, L 94.6, 106.6, 99.2 
     Chains M, N, O 110.2, 74.1, 80.3 
     Chains P, Q, R 94.9, 80.7, 98.2 
r.m.s.d. bond lengths [Å] 0.004 
r.m.s.d. bond angles [°] 0.99 
Values in parentheses are for the highest-resolution shell. 
 
 
4.3.4 Affinity Determination of Fabs for σ1 
Surface plasmon resonance (SPR) experiments with immobilized σ1 heads and Fabs as 
analytes were conducted to obtain affinity and kinetic data for the interaction of σ1 with 
Fabs (Figure 4.23). Both, 5C6 and 9BG5 Fabs bound their target σ1 with low nanomolar 
affinity following a 1:1 Langmuir interaction model. The KD values of the Fab-σ1 
interactions are similar, with 2.0 (± 0.1) × 10-9 M for T1L σ1-5C6 and 2.5 (± 0.2) × 10-9 M 
for T3D σ1-9BG5, but the binding kinetics differ. The T1L σ1-5C6 Fab complex has 
significantly lower association and dissociation rates compared to the T3D σ1-9BG5 Fab 
complex. 
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Figure 4.23 Kinetics of Fab binding to σ1. Representative SPR-binding studies of the T1L σ1 head 
with 5C6 Fabs (A) and the T3D σ1 head with 9BG5 Fabs (B). The σ1 protein was immobilized on a 
sensor chip, and twofold dilutions of Fab fragments were injected in duplicate. Fab concentrations 
ranging from 280 to 8.8 nM for 5C6 (A) and from 37.5 to 0.6 nM for 9BG5 (B) are indicated at the right 
of each sensorgram. The data sets were globally fitted (red lines) to a 1:1 Langmuir binding model. 
The corresponding χ2 values are indicated in the table below. (C) The KD values and, association (ka) 
and dissociation (kd) constants and their standard deviations were determined using three 
independent measurements.  
 
4.3.5 Affinity Determination of hJAM-A for σ1 
SPR experiments with immobilized σ1 heads and the human JAM-A ectodomain as 
analyte were conducted to determine affinities of T1L and T3D σ1 for JAM-A 
(Figure 4.24). The JAM-A molecule bound to both T1L and T3D σ1 with high nanomolar 
affinities with average KD values of 2.0 (± 0.1) × 10-7 M for T1L σ1 and 5.3 (± 0.5) × 
10-7 M for T3D σ1. Due to high on- and off-rates of JAM-A binding to σ1, kinetic 
parameters of the interaction could not be determined. 
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Figure 4.24 SPR studies of JAM-A binding to σ1. Representative sensorgrams of 10 different JAM-
A concentrations (A: 0.02 to 10 μM, B: 0.04 to 20 μM) injected in duplicate over immobilized T1L σ1 
(A) and T3D σ1 (B), respectively, at 25°C. Red boxes indicate the range used for calculation of 
equilibrium response values. Binding curve of JAM-A to T1L σ1 (C) and T3D σ1 (D). The equilibrium 
response values are plotted against the injected JAM-A concentrations. KD values are indicated. 
Copyright © American Society for Microbiology, JVI, 89, 2015, 6136-6140, doi:10.1128/JVI.00433-15.   
 
4.3.6 JAM-A Binding to σ1-mAb complexes 
To investigate whether JAM-A can engage σ1 saturated with neutralizing antibodies, I 
conducted SPR-measurements with the σ1 head domain immobilized on a biosensor 
chip (Figure 4.25).  
The response of 5C6 Fabs (~160 RU) and the JAM-A ectodomain (~71 RU) to σ1 was 
tested first. 5C6 antibodies were injected twice and Fabs were applied to the surface 
immediately afterwards to determine whether all accessible binding sites of σ1 were 
engaged by the mAbs. Injection of the JAM-A ectodomain followed and the response 
level increased (~67 RU), indicating binding of the soluble protein to a T1L σ1-5C6 mAb 
complex. After surface regeneration, the response level of JAM-A or 5C6 Fabs was 
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tested again and showed that a similar amount of JAM-A can bind to σ1 alone and to a 
σ1-mAb complex.  
In the case of T3D σ1, 9BG5 mAb injection was directly followed by an injection of 9BG5 
Fabs to determine whether all accessible σ1 epitopes were bound by the mAbs. A 
second injection of 9BG5 mAbs to surface saturation was followed by injection of the 
JAM-A ectodomain. The response level increased (~ 30 RU), suggesting binding of the 
soluble JAM-A protein to a T3D σ1-9BG5 mAb complex. Response levels of 9BG5 Fabs 
and JAM-A (27 RU) to σ1 alone were evaluated after surface regeneration and showed 
that similar amounts of JAM-A can bind to σ1 alone and to the σ1-mAb complex. 
 
Figure 4.25 Binding of the soluble ectodomain of reovirus receptor JAM-A to σ1 complexed 
with mAbs. Shown are reference SPR sensorgrams. (A) JAM-A binding to immobilized T1L σ1 
complexed with 5C6 mAbs was observed. Control experiments pre- and post-complex formation with 
JAM-A and 5C6 Fabs were performed and showed that similar amounts of JAM-A bound to σ1 alone 
and to a σ1-mAb complex. (B) JAM-A binding to immobilized T3D σ1 complexed with 9BG5 mAbs 
was observed. Control experiments after regeneration of the σ1 surface with 9BG5 Fabs and JAM-A 
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were performed and showed that similar amounts of JAM-A bound to σ1 alone and to a σ1-mAb 
complex. 
5 Discussion 
5.1 The σ1-Tail Domain 
5.1.1 Anchoring of σ1 in the Virus 
The trimeric reovirus attachment protein σ1 is anchored at the five-fold axis of the virion 
by interacting with the pentameric λ2 protein. The first N-terminal ~ 25 amino acids of σ1 
are thought to contact λ2, and as the sequence possesses a heptad repeat pattern, this 
part of the protein is predicted to form a small coiled coil that is appended to the rest of 
the tail domain by a short linker region [60,113].  
EM reconstructions of reovirus virions and ISVPs revealed small density features 
corresponding to σ1 protruding from the center of the λ2 turrets [28]. Comparison of 
reconstructions of particles that have σ1 bound and particles that lack σ1 showed density 
features just above and beneath the top of the λ2 turret, indicating that the σ1 anchor is 
incorporated within the pentameric λ2 protein [114,115]. The density feature of σ1 within 
the λ2-cavity forms a knob like structure.  
A deeper understanding of the structural features underlying the symmetry-mismatch, 
the unusual interaction between the pentameric λ2 and the trimeric σ1 proteins, would 
shed light on assembly and disassembly processes of the virus. To investigate whether 
the N-terminus of σ1 has a defined structure in the absence of λ2, a crystal structure of a 
T3D σ1 construct comprising residues 1-168 was solved. The σ1 trimer is formed by 
crystallographic three-fold symmetry, but there is no electron density visible for the 
residues of interest (amino acids 1-24). This finding indicates that this part of the protein 
is either too flexible or unstructured to be resolved in the electron density. It is therefore 
impossible to say whether the N-terminus of σ1 is structured or not.  
It is possible that the six non-native amino acids at the N-terminus of σ1, a remnant from 
cloning, influence the σ1 structure. Therefore, and also to compare the findings with T1L 
σ1, a new construct, SUMO-T1L σ1(2-178), was cloned and is currently under 
investigation. This construct has the advantage that, after tag-cleavage with the protease 
UlpI, no additional non-native amino acids remain appended to the σ1 protein.  
It is unlikely that the coiled coil region of the tail domain (amino acids 25 onwards) found 
in the T3D σ1(1-168) structure would correspond to the knob-like density feature within 
the λ2-cavity as the opening of λ2 spans only ~ 15 Å, while the coiled coil has a diameter 
of ~ 25 Å. It remains possible that the N-terminal region of σ1 requires an interaction with 
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λ2 to become folded and that the small predicted coiled coil corresponds to the knob-like 
density observed by EM analysis, while the flexible linker penetrates the λ2 channel. 
The current model predicts that σ1 cannot escape λ2 in virions and ISVPs, as the 
channel at the center of λ2 is too narrow. During ISVP-to-core transition, λ2 undergoes a 
conformational change that increases the width of the channel allowing release of σ1 that 
poorly binds to cores [28]. The recoating of cores with µ1/σ3 causes λ2 to rearrange into 
its closed conformation. Except for the appearance of the knob-like density, recoating 
with additional σ1 does not induce further major changes in the capsid. Therefore, it is 
hypothesized that σ1 assembles before or in concert with µ1/σ3 [115]. An experiment, 
such as adding µ1/σ3-recoated core particles to σ1 containing cell lysate and testing for 
σ1 insertion would be informative.  
The λ2 protein forms solely monomers when it is expressed alone and requires the 
scaffold of the core to form pentamers. To strengthen the model that σ1 is incorporated 
into λ2 pentamers, and to further investigate the symmetry mismatch, one could recoat 
core particles with µ1/σ3 and shorter σ1 proteins containing photo-reactive amino acids 
at the N-terminus for site-specific cross-linking. Photo-reactive unnatural amino acids 
such as photo-Met or photo-Leu could be incorporated into σ1 either during recombinant 
protein production or via peptide synthesis [116,117]. Other photo-reactive amino acids 
such as p-benzoyl-L-phenylalanine, which can be incorporated into biomolecules by 
genetic code expansion methods, might be too bulky for this experiment. Furthermore, 
the heterologous production of the σ1 tail yields high protein amounts and enables 
recombinant modifications, e.g., the specific introduction of cysteine residues for labeling 
with Alexa fluorophores for FRET-based approaches, that might be useful to determine 
whether the N-terminus of σ1 has a defined structure. NMR spectra of T1L σ1(2-178) 
and NMR spectra of T3D σ1(1-168) compared with T3D σ1(25-168), which both have the 
same six non-native amino acids, would be a different and more elegant way to 
determine whether the σ1 N-terminus is structured.  
Reovirus σ1 and adenovirus fiber share functional and structural properties [63]. Both 
proteins mediate cell-attachment, possess a fibrous domain composed of triple β-spiral 
repeats, have a globular head domain, and are associated with the virus at the 
icosahedral vertices. However, most data suggest that the two trimeric proteins have 
different approaches to encounter the ‘3-5’ symmetry-mismatch. The virus-anchoring 
region of adenovirus fiber is larger than the expected region of σ1 and has in comparison 
no predicted secondary structure but a highly conserved region among the adenovirus 
serotypes. Compared to σ1, adenovirus fiber is thought to interact at the outer surface of 
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the pentameric vertex-protein using monomeric “cables” for binding between two 
subunits. Several EM analyses of adenoviruses and crystal structures of the pentameric 
protein complexed with fiber peptides support this model [64,118]. However, one crystal 
structure of a chimeric virus exists that reveals electron density proposed to belong to the 
fiber within the central cavity of the pentameric protein [119]. This interaction was 
suggested to represent an intermediate state during virus cell entry or assembly 
[118,119]. 
 
5.1.2 The σ1 Coiled Coil 
Prior to this work, crystal structures of only two small regions of the T1L σ1 tail (residues 
29-78 and 120-160) that are both N- and C-terminally flanked by (GCN4)3 were known 
(Reiss, Dissertation, 2013). To investigate whether the σ1 tail can independently form a 
stable trimeric coiled coil or whether its trimeric structure is enforced by the trimerization 
units, longer T1L σ1 constructs with or without a single N-terminal (GCN4)3-motif were 
purified and crystallized.  
The proteins elute from SEC-columns at retention volumes corresponding to globular 
proteins of higher molecular weight, reflecting a large hydrodynamic radius due to the 
rigidity of the elongated molecules. The T1L σ1(29-158) protein is stable across broad 
pH- and temperature ranges, as determined by circular dichroism measurements, 
indicating that the (GCN4)3-motif is not required for multimerization of the protein. Both 
crystal structures revealed trimeric helical bundles with two chloride ions bound in the 
center of the coiled coil. 
Superpositions of the σ1 structure lacking (GCN4)3 with the σ1 structures containing 
(GCN4)3 yield high r.m.s.d. values (Table 5.1). The extent of the deviation is higher for 
the longer constructs. This finding indicates that the trimerization unit constrains the σ1 
structure, causing deviations of the winding that add up along the α-helix and casts doubt 
on the usefulness of the fusion-tag in this particular case. However, differences in crystal 
packing and crystal contacts also might influence the winding.  
In comparison, the tail domain residues that are defined well in the electron density 
(residues 29-95, chain A) of the two T3D σ1 crystal structures, T3D σ1(1-168) and T3D 
σ1(25-291), that do not contain a (GCN4)3-motif and differ in the space group and crystal 
contacts, align with an r.m.s.d. value of 0.26 Å (main chain) or 0.54 Å (all atoms).  
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Table 5.1 Superposition of the untagged σ1 protein with (GCN4)3-carrying fragments of 
T1L σ1 tail domain structures. Coordinates of similar σ1-residues were superimposed by 
LSQ (chain A only) or SSM superpose (chain ABC). 
T1L σ1(29-159) 
 
Main chain  
(chain ABC) 
Main chain 
(chain A) 
All atoms 
(chain A) 
(GCN4)3-T1L σ1(120-160)-(GCN4)3 1.37 Å 0.65 Å 1.24 Å 
(GCN4)3-T1L σ1(29-78)-(GCN4)3 - 0.90 Å  1.52 Å 
(GCN4)3-T1L σ1(29-158) 2.50 Å 1.78 Å 2.15 Å 
 
 
Interhelical salt bridges between positions g and e+1 contribute approximately 1.5 kJ/mol 
to the coiled coil stability, and the charge patterns at those positions influence the 
preference for homo- or heterotypic or parallel or antiparallel pairing as well as the 
oligomerization state of an α-helical bundle [120,121].  
The coiled coils of T1L σ1(29-158) and T3D σ1(25-291) are stabilized by several 
interhelical salt bridges along the σ1 tail domain (Figure 5.1, Appendix helical wheel). For 
the T3D σ1 structure, all predicted charge-mediated interactions between adjacent α-
helices are present, while for the T1L σ1 structures, two such interactions are not part of 
the construct, one formed between E27 and K32 at the N-terminus, and one formed 
between R171 and E176 at the C-terminus of the tail.  
Few interhelical salt bridges involve residues at positions other than g and e+1, such as 
the interaction between R153 and D155 of T1L σ1 or between E159 and R161 of T3D 
σ1. These interactions are likely made possible by the locally altered geometry caused 
by the stutter. The interaction between R120 and D122 of T3D σ1 that occupy e and g 
positions of the same heptad is likely linked to the presence of H123 at the following core 
position. The histidine side chain is bulky and hydrophilic and leads to a local increase of 
the coiled coil pitch, making a salt bridge between R120 and D122 possible. 
 74 
 
 
Figure 5.1 Amino acid sequence alignment of residues 1-200 of T1L, T2J, and T3D σ1. The 
heptad repeats (abcdefg)n of the tail domain are indicated and highlighted in alternating light and dark 
brown shading. Typically hydrophobic positions a and d are bold. Red asterisks mark the start and end 
of T1L σ1(29-158), and a blue asterisk marks the N-terminal start of T3D σ1(25-291). Charged 
residues that form interhelical salt bridges of adjacent α-helices are highlighted in blue, and the acid 
base pairs are connected by underlines. The stutter is framed with a red box. Hydrophilic residues that 
occupy positions a and d are highlighted in red. A conserved Asn residue of the body domain is 
highlighted in green. 
 
The hydrophobic core provides the largest contribution to the overall stability of an α-
helical bundle [120]. In most coiled coils, a small percentage of polar core residues are 
present that add oligomerization and orientation specificity at the expense of stability. 
Here, T1L σ1 harbors two threonines at a positions and two asparagines at d positions, 
while T3D σ1 has a serine, two histidines, and an arginine at a and d positions. The main 
electron density for the arginine (R67) is shifted to the outside of the core and forms a 
hydrogen bond with S66 of an adjacent α-helix (Figure 5.2). Little density is present in 
the core of the 2.25 Å resolution structure of T3D σ1(25-291), while the unbiased Fo-Fc 
electron density map of the 1.6 Å resolution structure of T3D σ1(1-168) indicates 
alternative conformations for R67, so that one arginine in one of the three chains at a 
time is present in the core (Figure 5.2). 
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Figure 5.2 Residue R67 of T3D σ1 occupies a typically hydrophobic a position. Close up view 
along the three-fold axis. The σ1 chains are colored in blue, red, and yellow in the 2.25 Å resolution 
structure of T3D σ1(25-291) (A) and yellow and grey (symmetry mates) in the 1.6 Å resolution 
structure of T3D σ1(1-168) (B). The 2Fo-Fc electron density map is contoured in blue at 1.0 σ, and the 
Fo-Fc map is contoured in green at 3.0 σ and in red at -3.0 σ. The residue R67 is shifted out of the core 
and towards the surface of the coiled coil, where it interacts with S66 of an adjacent α-helix. Unbiased 
electron density inside the core indicates an alternative conformation of R67 that is modeled in (B) and 
shows that one R67 residues at a time can be present inside the core.  
 
Acidic and basic amino acids that occupy core positions play important roles in the pH-
dependent structural rearrangements of known coiled coil-containing proteins, such as 
influenza hemagglutinin or macrophage scavenger receptor [122,123]. Peptides 
composed of 4-5 heptad repeats with amino acid substitutions of Glu or His at core 
positions were investigated for pH-induced conformational changes [124,125]. At certain 
pH values, these residues are charged causing interhelical electrostatic repulsion at the 
core that destabilizes the coiled coil and leads to a random structure. 
Of the three reovirus serotypes, only T3D σ1 possess basic histidines at core positions 
that point inside. CD measurements of the tail domain could indicate a pH-dependent 
influence on the coiled coil structure. However, as the histidines are separated from each 
other by eleven heptad repeats it is likely that a destabilization at low pH will be 
compensated by the surrounding helices. The other two serotypes do not have charged 
residues at similar locations and, thus, it seems unlikely that the histidines play a crucial 
role in the assumed conformational rearrangement of σ1.  
Histidines within a helical bundle can function as ligands for various ions [126,127]. Only 
water molecules are bound within the T3D σ1 protein structure. It is possible that a 
different crystallization condition or metal ion soaking of the obtained crystals would 
reveal a structure with bound ions.  
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T1L σ1 harbors two and T2J σ1 harbors one asparagine at d positions. The asparagines 
of T1L σ1 coordinate halogenide ions in the hydrophobic core, a characteristic property 
that has been observed in other trimeric coiled coils [128]. Asparagines at the core 
positions that have been substituted with hydrophobic amino acids in other coiled coil 
structures led to a loss of structural specificity. The asparagines present in T1L σ1 and 
T2J σ1 also might act as additional trimerization determinants necessary for proper 
assembly of the α-helical bundle. Residue H42 of T3D σ1 is located at a position similar 
to N38 of T1L σ1, and it also might influence the trimeric aligning of the σ1 subunits. 
Uninterrupted heptad repeats are predominantly found in short coiled coil structures, 
e.g., in transcription factors, while heptad breaks (stutter, stammer) are encountered in 
many longer coiled coil domains [68]. These discontinuities can be tolerated by a local 
distortion of the geometry that is generally confined to two α-helical turns on both sides of 
the heptad break [69,120]. The local geometry change is assumed to either terminate the 
structural motif or contribute to the flexibility of longer coiled coil structures. Heptad 
breaks can modify the assembly of a protein and its interaction properties, as was shown 
in an analysis of a stutterless vimentin [129]. Stutter positions also are highly conserved 
in many viral fusion proteins, suggesting a functional role in proteins that often adopt 
different conformations. 
In the σ1 proteins of all three serotypes, the stutter position close to the C-terminal end of 
the coiled coil is conserved. Following the stutter, T1L σ1 has two heptad repeat 
insertions and T2J σ1 has one heptad repeat insertion relative to T3D σ1. The stutter 
sequences lead to a local unwinding of the coiled coil and the α-helices in the T1L σ1 
and T3D σ1 structures. This unwinding causes the formation of a da-layer, and a 
hydrophilic interaction between the conserved threonine at position b of the stutter and 
the conserved arginine (position g-1) of an adjacent α-helix.  
To further define the role of the observed features of the T1L σ1 and T3D σ1 tail 
domains, mutant σ1 proteins were engineered. In T1L σ1, the core asparagines were 
replaced with hydrophobic amino acids, and in T3D σ1, stutterless tail domains were 
engineered through either an insertion of three additional amino acids or a deletion of the 
four stutter residues. Mutant viruses were recovered using the reverse genetics 
approach, and their viral attachment and cell entry properties are currently being 
analyzed to define the effect of the engineered mutations in a physiological setting. This 
analysis also may reveal whether the ions in the core or the conserved stutter serve 
crucial roles in σ1 function.  
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5.2 The σ1 Tail-Body Junction 
EM images of the σ1 protein isolated from virions by mild heating show three regions of 
greater flexibility, one close to the N-terminus, one at the midpoint of the molecule that 
correlates with the junction of the tail and the body domain, and one close to the head 
domain [61]. These flexible parts could facilitate a structural rearrangement of σ1 during 
viral disassembly or assembly.   
The region just below the head was indeed shown to be flexible by previous 
crystallographic analyses of σ1 [63]. To investigate the remaining two regions of 
predicted flexibility, T1L and T3D σ1 proteins comprising these regions were purified and 
crystallized. As discussed above, the N-terminal part of the T3D σ1(1-168) structure is 
not resolved in the electron density, likely because of its highly flexible nature or 
conformational heterogeneity. 
The structure of T3D σ1(25-291) comprises the tail and a portion of the body domain and 
reveals a seamless transition of the two domains. Backbone-backbone interactions 
between valines V170 of the three chains at the transition site and direct interactions 
between N182 of the body and carbonyl groups of E166 and A169 at the end of the 
coiled coil stabilize the junction of the two domains. Thus, the structure does not readily 
explain the flexibility at the midpoint of σ1 observed in the EM images. 
The valine and threonine at the domain junction, as well as the asparagine that interacts 
with the coiled coil, are also conserved in the body domains of T1L and T2J σ1 
(Figure 5.1, page 74). An interhelical salt bridge that stabilizes the C-terminal end of the 
T3D σ1 coiled coil is also predicted in the sequence of the other two serotypes. 
Therefore, it is likely that the transition of the tail to the body domain of T1L and T2J σ1 is 
similar to the T3D σ1 structure.  
In T1L σ1, a methionine is located at the end of the coiled coil (analogous to A169 of 
T3D σ1), and the presence of this larger residue might lead to a larger coiled coil 
diameter at the transition site compared with T3D σ1. X-ray diffraction data were 
obtained for crystals of a T1L σ1 construct comprising the coiled coil and a portion of the 
body domain, and the data are currently being processed. The crystal structure of this 
protein will likely elucidate features of the tail-body junction in T1L σ1 and clarify whether 
its structure is indeed similar to T3D σ1. 
The structural information obtained for T3D σ1(25-291) can be combined with the known 
T3D σ1 structure consisting of the body and the head domain (PDB ID: 3S6X). The main 
chains of the body domain present in both structures align with a low r.m.s.d value of 
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0.34 Å (all atoms: 0.63 Å) and result in a high-resolution model of σ1 that fits well with 
the elongated EM reconstruction of full-length T2J σ1 (Figure 5.3). 
 
 
Figure 5.3 Model of T3D σ1 superimposed on a computer-processed electron micrograph of 
T2J σ1. (A) The T3D σ1 model is assembled by combining the residues 27-243 of the T3D σ1(25-
291) structure with residues 244-455 of PDB ID: 3S6X (after alignment of the identical parts of the 
body domain). Both structures used for the model have a resolution of 2.25 Å. The model is colored 
according to B-factors from blue (20 Å2) to red (120 Å2). The T3D σ1 model is superimposed onto a 
computer-processed electron micrograph of T2J σ1 adapted from [61]. (B, C) Electron micrographs of 
T2J σ1 molecules isolated from virions show kinks at two different region of the molecule [61]. Figure 
used with permission. 
 
The head and body domains of σ1 are connected by a linker region that allows 
movement between the two domains and explains the flexibility of the molecule near the 
head domain [17,19,63]. Within the T3D σ1(25-291) structure, no such intrinsic flexible 
region was observed that could account for the flexibility in the middle of the σ1 protein. 
Instead, it is possible that conformationally distinct, stable states of σ1 exist in which the 
tail and body have different but defined orientations.  
In the study of Fraser et al. [61], just a minor fraction (2-4%) of the σ1 particles showed 
kinks near the midpoint of the molecule. This rare observation could be an artifact, a 
result of the harsh sample preparation that included heating of the virus to 52°C for 
30 min (to release σ1) and negative staining using uranyl formate that might affect the 
protein structure. The comparison with EM micrographs of recombinant σ1 could give 
some more hints about the flexibility of the molecule. Therefore, the T1L and T3D σ1 
constructs of different lengths that comprise the coiled coil tail and parts of the body 
domain, as well as T1L σ1(29-470) that is composed of the tail, body, and head domains, 
might be useful. The initial purification test of SUMO-T1L σ1(2-470) looked promising, 
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and it is probably worthwhile to investigate this construct further. In comparison to the 
untagged T1L σ1(29-470) protein, the construct possesses additional N-terminal amino 
acids, and the purification could be simpler and less time-consuming. 
The contribution of direct body-tail domain interactions to the stability of σ1 and the effect 
of the interhelical salt bridge at the end of the coiled coil could be investigated with 
mutant σ1 proteins in the proposed EM study. Proteins that are more flexible at the 
midpoint of the molecule might increase the percentage of kinked or bent structures 
within the sample. 
To investigate whether the observed tight and stable transition of the two domains has 
an influence on the function of σ1, mutant T3 reovirions with alterations in the tail, such 
as a N182A point mutation, have been recovered and will be tested for attachment, 
internalization, disassembly, and membrane penetration.  
While the B-factors for residues at the tail-body junction are low in the T3D σ1(25-291) 
structure, the residues that belong to the small coiled coil that directly follows β-spiral 
repeat β4 have negligable electron density and high B-factors. The T3D σ1(170-455) 
structure of PDB ID 3S6X has similar low B-factors for the N-terminal part of the body 
domain (β1-β4) and high B-factors for the small coiled coil and the following β-spiral 
repeats β5-β7 (Figure 5.3). Higher temperature factors indicate a higher degree of 
thermal mobility within a molecule or regions that are involved in fewer crystal contacts.  
The susceptibility of T3D σ1 to protease cleavage within the coiled coil of the body 
domain and the finding that the point-mutation T249I, which has a stabilizing effect on 
the coiled coil, renders the protein resistant to proteolytic cleavage is a further indication 
for some flexibility in this region. 
Due to the low resolution and signal-to-noise ratio of the EM micrographs in the Fraser et 
al. study [61] and the low percentage of particles kinked in the middle of the fiber, 
determination of the region of higher flexibility is somewhat imprecise. New EM images 
of σ1 with a better resolution could better define locations of flexibility. 
The evidence that σ1 undergoes an extensive structural rearrangement is based on prior 
EM studies [28,29], and further experiments are required to support this hypothesis. 
Assuming that σ1 has a defined and compact conformation on virions, complexes with 
σ1 specific antibodies, such as 9BG5 or 5C6, would trap σ1 and reveal a defined pattern 
of the mAbs on the virus surface on EM images. If it is indeed the case that σ1 has a 
linear, elongated structure when present on ISVPs but is non-linear and hidden on the 
virus surface due to possible interactions with σ3 or σ3/µ1, complexes with σ1-specific 
mAbs would reveal a non-uniform pattern of mAb-spiked particles.    
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5.3 σ1 Interactions with Neutralizing Antibodies 
Figures and text are adapted with permission: Copyright © American Society for 
Microbiology, JVI, 91 2017, doi:10.1128/JVI.01621-16. 
5.3.1 Strategies for Viral Escape from Antibody Neutralization 
Previous analysis of reovirus variants that resist neutralization of 5C6 or 9BG5 have 
identified two residues in the T1 and T3 σ1 head domains critical for antibody recognition 
[92,98]. The crystal structures of complexes between T1L σ1 with 5C6 Fabs and T3D σ1 
with 9BG5 Fabs presented here have elucidated the complete antibody-binding sites and 
provide insights into the strategies by which the reovirus variants escape neutralization.  
T1 reovirus variants that are resistant to 5C6 display point mutations Q417K or G447S. 
Residue Q417σ1 is engaged by the carbonyl group of 5C6 residue Y102H3. The mutation 
Q417K likely would sterically hinder Y102H3 and Y104H3 interactions with σ1, and the 
introduced positive charge next to R424σ1 might locally alter the σ1 structure due to 
electrostatic repulsion. G447σ1 is not directly involved in interactions with 5C6. The effect 
of mutant G447S on neutralization likely results from a diminished residue flexibility. The 
larger side chain probably alters the local protein structure and prevents binding of CDR 
H3 to σ1. 
Mutant viruses of T3 that escape 9BG5-neutralization display the single mutation D340V 
or E419K and are less neurovirulent in mice than the wildtype virus, suggesting that a 
step in the viral life cycle is altered by these mutations. The mutation D340V introduces 
an aliphatic amino acid that results in the loss of the charge-mediated interaction with 
R51L2 of 9BG5. Residue E419σ1 forms several hydrogen bonds with 9BG5. The mutation 
E419K inverts the residue charge and likely weakens the interaction with 9BG5 due to 
direct disruption of contacts with 9BG5 residues S30L1, S31L1, and N32L1. 
 
5.3.2 Effects of 5C6 and 9BG5 on σ1-Binding to Glycan Receptors  
Reoviruses are thought to use an adhesion-strengthening mechanism for cell-attachment 
in which low-affinity binding of σ1 to cell-surface glycans is followed by high-affinity 
binding to JAM-A. The glycan binding site of T1L σ1 is located in the head domain and is 
in direct proximity to the 5C6 epitope (Figure 5.4). Residues Q371σ1 and T373σ1 are part 
of the GM2 glycan binding site as well as the 5C6 epitope of T1L σ1. The location of 
CDR H1 reduces the available space at the carbohydrate binding site and could 
therefore directly block low-affinity engagement of the glycan receptor (Figure 5.4C). 
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Hemagglutination (HA) inhibition assays showing that 5C6 mAbs and Fabs efficiently 
block T1L virions and ISVPs to agglutinate human erythrocytes substantiate this finding.   
 
 
Figure 5.4 Receptor and antibody binding sites on T1L and T3D σ1. Surface representation of σ1 
structures. Residues that contact receptors and the mAb within a distance cutoff of 5 Å are colored. 
The JAM-A binding sites are shown in green, glycan binding sites are blue, the 5C6 epitope is colored 
in light (light chain) and dark (heavy chain) brown, and the 9BG5 epitope is colored in light (light chain) 
and dark (heavy chain) violet. (A) T1L σ1 head. (B) T3D σ1 body and head. (C) Close up view 
showing that the 5C6 epitope overlaps with the glycan binding site of T1L σ1. The residues Q371σ1 
and T373σ1 interact with GM2 (blue) as well as with CDR H3 (black) of 5C6. The CDR H1 (light grey) 
occludes the glycan receptor binding site and would hinder GM2-binding due to the reduced space of 
the receptor binding site. 
 
The carbohydrate binding site of T3D σ1 is located at the N-terminal part of the body 
domain, while the 9BG5 epitope is located in the head domain (Figure 5.4B). Therefore, 
it would not be anticipated that 9BG5 binding would directly interfere with sialic acid 
engagement.  
In HA inhibition assays, 9BG5 mAbs and Fabs efficiently block HA by T3SA+ virions, but 
neither 9BG5 mAbs nor Fabs inhibit HA by T3SA+ ISVPs. This finding supports the 
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hypothesis that σ1 adopts a more compact conformation on virions than on ISVPs. On a 
compact virus-bound arrangement, the 9BG5 epitope on the σ1 head could be in close 
spatial proximity to the carbohydrate-binding site on the σ1 body domain and would thus 
be able to interfere with glycan receptor engagement. During virion-to-ISVP conversion, 
σ1 likely adopts the elongated conformation observed in the crystal structure [19], where 
the 9BG5 epitope is sufficiently distant to the glycan-binding site (~120 Å) such that an 
IgG molecule probably could not sterically hinder binding of σ1 to the glycan receptor. 
 
5.3.3 Effects of 5C6 and 9BG5 on σ1-Binding to JAM-A 
The binding site of the serotype-independent receptor JAM-A is conserved in T1 and T3 
reoviruses and located at the lower part of the σ1 head domain (Figure 5.4, page 81). 
Both the 5C6 epitope that is located close to the top of the σ1 head and the 9BG5 
epitope in the middle of the σ1 head span two σ1 subunits and are distinct from the 
JAM-A receptor-binding site.  
SPR studies using immobilized σ1 are consistent with this finding and demonstrated that 
the soluble JAM-A ectodomain can additionally bind to σ1 complexed with 5C6 or 9BG5. 
This finding indicates that the two mAbs do not neutralize reovirus infection by direct 
blockade of the JAM-A receptor-binding site.  
Reovirus binding to JAM-A expressed on CHO cells is inhibited by the cognate mAbs 
and Fabs. If σ1 can bind 5C6 or 9BG5 and JAM-A simultaneously, then by what 
mechanism is the neutralization of reovirus infection by 5C6 and 9BG5 accomplished? 
The membrane-associated JAM-A protein extends from the cell by about 80-90 Å, and 
the binding site for σ1 is located on the most membrane-distal Ig-like domain. JAM-A is 
engaged by σ1 residues on the lower part of the σ1 head, adjacent to the body domain. 
Modeling indicates that reovirus binding to JAM-A on the cell surface would bring the top 
of the σ1 head domain into close proximity with the cell membrane (Figure 5.5A).  
Up to three mAbs can bind to one σ1 trimer, and taking geometric considerations into 
account, one antibody can engage one binding site of one σ1 molecule with one Fab but 
would not be able to engage the same trimer by binding another epitope with the second 
Fab. A σ1-bound mAb could probably not bind with its second Fab to a different σ1 
protein on the surface of the same virion due to the large distance between the 
icosahedral five-fold axes. Due to the minor presence of σ1 on the virus particle, binding 
to a σ1 protein of another reovirus virion (with the second Fab) seems also unlikely to be 
important for neutralization.  
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When 5C6 or 9BG5 antibodies bind to σ1, the virus almost certainly could not engage 
JAM-A, as the membrane-anchored receptor could not reach its binding site on the σ1-
surface. The affinity of both 5C6 and 9BG5 Fabs for their cognate σ1 proteins is around 
100-fold stronger than the affinity of JAM-A for σ1. Thus, it is unlikely that JAM-A 
competes for binding to σ1 and suggests that the mechanism of antibody interference 
with reovirus binding to JAM-A is based on indirect steric hindrance with the cell 
membrane (Figure 5.5B). 
 
 
Figure 5.5 Model of the proposed neutralization mechanism of 5C6 and 9BG5 blocking σ1-
binding to membrane-associated JAM-A by steric hindrance with the cell-surface. The full-length 
model of T3D σ1 (PDB ID: 3S6X connected with T3D σ1(25-291)) is colored in blue, the membrane-
bound ectodomain of JAM-A (PDB ID: 1NBQ with an additional five amino acids added at the C-
terminus using coot) is colored in green, and antibodies (PDB ID: 1IGT, aligned with 9BG5 Fabs via 
the antigen binding fragments) are colored in light and dark purple. The cell surface is indicated by a 
plane colored in grey. (A) Binding of σ1 to JAM-A on the cell-surface brings the top of the σ1 head in 
close proximity with the cell-membrane. (B) 9BG5-bound σ1 close to the cell surface (for clarity only 
two mAbs are shown). The bulky antibodies would clash with the cell-surface, impede JAM-A binding.  
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5.3.4 Neutralization Recognition of other Virus Fiber Proteins 
While the mechanism of reovirus neutralization may be mainly explained by interference 
with receptor binding at the cell surface, it is conceivable that 5C6 and 9BG5 also impair 
later steps in the infectious cycle. The 5C6 and 9BG5 binding sites are well placed to 
hinder a possible structural change in σ1 that may be important for reovirus cell-uptake. 
Both epitopes bridge σ1-subunits and thus are conformationally dependent. Such a 
binding mode is also shared by neutralizing antibodies directed against stalk-like 
attachment proteins of other viruses.    
The hemagglutinin of influenza virus is a trimeric molecule that consists of a globular 
head, which mediates binding to cell-surface glycan-receptors, and a stem region, which 
mediates fusion of the viral envelope with the cellular membrane. Broadly neutralizing 
mAbs that are directed against the highly conserved stem region of hemagglutinin bind 
across the two subunits (HA1 and HA2) of a protomer and lock the protein in the pre-
fusion conformation. Thus, the mAbs inhibit a conformational change of the protein that 
is required for membrane fusion [130].   
A similar neutralization strategy is observed for rotaviruses, which also belong to the 
Reoviridae family. The rotavirus attachment protein, VP4, is a spike-like molecule that 
consists of two fragments, VP5* and VP8*, which are generated by proteolytic cleavage 
[131]. The body of the spike is formed by VP5*, which contains the hydrophobic 
membrane penetration domain. The distal globular head domain is formed by VP8*, 
which is involved in carbohydrate-receptor engagement. The core of VP5* has a fold that 
is similar to that of the head domain of reovirus σ1 [132].  
VP4 undergoes a conformational change from a local dimer to a trimer during cell entry. 
The neutralizing mAb 2G4 binds the dimeric form of VP4 in the cleft between the heads 
and prevents the irreversible reorganization of the protein to the trimeric state [133]. The 
binding site of 2G4 was mapped by an escape mutation located in the membrane 
penetration domain of VP5* [134], but the complete epitope is unknown, and a detailed 
understanding of the neutralization mechanism is therefore not yet possible. 2G4 also 
can bind to the trimeric VP4, but it remains possible that the mAb interacts with residues 
of VP8* and prevents the conformational change by spanning subunits. 
Common to these examples is a neutralizing mechanism in which the mAbs bind across 
subunits of a multimeric viral attachment protein and thereby stabilize a particular 
conformation that prevents a structural rearrangement of the protein. The anti-reovirus 
mAbs 5C6 and 9BG5 share the same, subunit-bridging strategy for binding attachment 
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protein σ1, suggesting a likely role for a σ1 conformational change during cell entry. In 
future studies, neutralizing and non-neutralizing mAbs that target σ1 on virions or ISVPs 
may serve as useful tools to probe the hypothesized, conformational rearrangement. 
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6 Appendix 
6.1 Construct Overview 
Construct Mwmonomer [kDa] ε280nm [M-1cm-1] pI  
SUMO-T1L (2-470)  64 (tagged) 
51 (untagged) 
60390  
58900 
5.3 
5.1 
pE-SUMOpro amp 
SUMO-T1L (29-470) 61 (tagged) 
48 (untagged) 
60390 
58900 
5.3 
5.0 
pE-SUMOpro amp 
His6-T1L σ1(29-470) 51 58900 5.8 pET28b kana 
T1L σ1(29-470) 48 58900 5.0 pET16b 
His6-T1L σ1(29-303) 32 (tagged) 
30(untagged) 
9970 
9970 
5.8 
5.0 
pET28b kana 
His6-T1L σ1(29-265) 28 (tagged) 
26 (untagged) 
8480 
8480 
6.0 
5.0 
pET28b kana 
His6-T1L σ1(29-249) 26 (tagged) 
24 (untagged) 
8480 
8480 
6.0 
5.0 
pET28b kana 
(GCN4)3-T1L σ1(29-159) 18 1490 4.9 pIBA-GCN4tri-His 
T1L σ1(29-159) 14 - 4.7 pET16b 
His6-T3D σ1(28/30-455) 49 (tagged) 39420 5.8 pET28b 
His6-T3D σ1(1-234) 28 (tagged) 
26 (untagged) 
- 6.1 
5.3 
pET28b 
His6-T3D σ1(1-291) 34 (tagged) 
32 (untagged) 
1490 
1490 
6.1 
5.3 
pET28b 
His6-T3D σ1(25-251) 27 (tagged) 
25 (untagged) 
- 6.3 
5.4 
pET28b 
His6-T3D σ1(25-291) 31 (tagged) 
29 (untagged) 
1490 
1490 
6.3 
5.5 
pET28b 
His6-T3D σ1(1-168) 21 (tagged) 
19 (untagged) 
- 5.8 
4.9 
pET28b 
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6.2 MALDI-MS: T3D σ1(25-291)  
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6.3 Helical Wheel Projections of T1L and T3D σ1 Tail Domain 
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